# EDGAR Filing Document

**Accession Number:** 0001061894
**File Stem:** 0001061894-26-000013
**Filing Date:** 2026-4
**Character Count:** 242031
**Document Hash:** 3bc99f301dc3e3de0594370fe96e3410
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001061894-26-000013.hdr.sgml**: 20260430

**ACCESSION NUMBER**: 0001061894-26-000013

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 8

**CONFORMED PERIOD OF REPORT**: 20260329

**FILED AS OF DATE**: 20260430

**DATE AS OF CHANGE**: 20260430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Gildan Activewear Inc.
- **CENTRAL INDEX KEY:** 0001061894
- **STANDARD INDUSTRIAL CLASSIFICATION:** APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** Z4
- **FISCAL YEAR END:** 0103

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14830
- **FILM NUMBER:** 26920141

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 600 BOULEVARD DE MAISONNEUVE OUEST
- **STREET 2:** 33RD FLOOR
- **CITY:** MONTREAL
- **PROVINCE COUNTRY:** A8
- **ZIP:** H3A 3J2
- **BUSINESS PHONE:** 5147352023

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 600 BOULEVARD DE MAISONNEUVE OUEST
- **STREET 2:** 33RD FLOOR
- **CITY:** MONTREAL
- **PROVINCE COUNTRY:** A8
- **ZIP:** H3A 3J2

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GILDAN ACTIVEWEAR INC
- **DATE OF NAME CHANGE:** 19980515

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

**Form 6-K**

**Report of Foreign Private Issuer**

**Pursuant to Rule 13a-16 or 15d-16 of**

**the Securities Exchange Act of 1934**

---

| | |
|:---|:---|
| **For the month of: April 2026** | **Commission File Number: 1-14830** |

---

**GILDAN ACTIVEWEAR INC.**

*(Translation of Registrant's name into English)*

**600 de Maisonneuve Boulevard West**

**33rd Floor**

**Montréal, Québec**

**Canada H3A 3J2**

*(Address of Principal Executive Offices)*

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F □ Form 40-F 🗹

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): □

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): □

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | **GILDAN ACTIVEWEAR INC.** | **GILDAN ACTIVEWEAR INC.** | **GILDAN ACTIVEWEAR INC.** |
| Date:&nbsp;&nbsp;&nbsp;&nbsp; April 30, 2026 | By: | /s/ Rob Assal | /s/ Rob Assal |
|  |  | Name: | Rob Assal |
|  |  | Title: | Executive Vice-President, Chief Legal and Administrative Officer and Corporate Secretary |

---

SEC 1815 (04-09) Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

------

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit** | **Description of Exhibit** |
| 99.1 | <u>[Management's Discussion and Analysis](exhibit991q12026mda.htm)</u> |
| 99.2 | <u>[Interim Financial Statements](exhibit992q12026fs.htm)</u> |
| 99.3 | <u>[Certifications of Interim Filings - CEO](exhibit993-q12026interimce.htm)</u> |
| 99.4 | <u>[Certifications of Interim Filings - CFO](exhibit994-q12026interimcf.htm)</u> |

---

## Exhibit 99.1

![reportlogonew.jpg](reportlogonew.jpg)

**2026 First Quarter**

**Shareholder Report**

---

| | |
|:---|:---|
| **Contents** | |
| MD&A |  |
| &nbsp;&nbsp;&nbsp;&nbsp;1.0 Preface | [2](#if7b928907be94af7a21a4874e9c5dd62_7) |
| &nbsp;&nbsp;&nbsp;&nbsp;2.0 Caution regarding forward-looking statements | [2](#if7b928907be94af7a21a4874e9c5dd62_10) |
| &nbsp;&nbsp;&nbsp;&nbsp;3.0 Our business | [4](#if7b928907be94af7a21a4874e9c5dd62_13) |
| &nbsp;&nbsp;&nbsp;&nbsp;4.0 Strategy | [9](#if7b928907be94af7a21a4874e9c5dd62_16) |
| &nbsp;&nbsp;&nbsp;&nbsp;5.0 Operating results | [9](#if7b928907be94af7a21a4874e9c5dd62_19) |
| &nbsp;&nbsp;&nbsp;&nbsp;6.0 Financial condition | [19](#if7b928907be94af7a21a4874e9c5dd62_22) |
| &nbsp;&nbsp;&nbsp;&nbsp;7.0 Cash flows | [21](#if7b928907be94af7a21a4874e9c5dd62_25) |
| &nbsp;&nbsp;&nbsp;&nbsp;8.0 Liquidity and capital resources | [23](#if7b928907be94af7a21a4874e9c5dd62_28) |
| &nbsp;&nbsp;&nbsp;&nbsp;9.0 Legal proceedings | [29](#if7b928907be94af7a21a4874e9c5dd62_31) |
| &nbsp;&nbsp;&nbsp;&nbsp;10.0 Financial risk management | [29](#if7b928907be94af7a21a4874e9c5dd62_37) |
| &nbsp;&nbsp;&nbsp;&nbsp;11.0 Critical accounting estimates and judgments | [30](#if7b928907be94af7a21a4874e9c5dd62_40) |
| &nbsp;&nbsp;&nbsp;&nbsp;12.0 Accounting policies and new accounting standards not yet applied | [30](#if7b928907be94af7a21a4874e9c5dd62_43) |
| &nbsp;&nbsp;&nbsp;&nbsp;13.0 Internal control over financial reporting | [31](#if7b928907be94af7a21a4874e9c5dd62_46) |
| &nbsp;&nbsp;&nbsp;&nbsp;14.0 Risks and uncertainties | [31](#if7b928907be94af7a21a4874e9c5dd62_49) |
| &nbsp;&nbsp;&nbsp;&nbsp;15.0 Definition and reconciliation of non-GAAP financial measures and related ratios | [32](#if7b928907be94af7a21a4874e9c5dd62_52) |
| Condensed interim consolidated financial statements | 43 |
| Notes to the condensed interim consolidated financial statements | 47 |

---

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**1.0 PREFACE** 

In this Management's Discussion and Analysis (MD&A), "Gildan", the "Company", or the words "we", "us", and "our" refer, depending on the context, either to Gildan Activewear Inc. or to Gildan Activewear Inc. together with its subsidiaries.

This MD&A comments on our operations, financial performance, and financial condition as at and for the three months ended March 29, 2026. All amounts in this MD&A are in U.S. dollars, unless otherwise noted. For a complete understanding of our business environment, trends, risks and uncertainties, and the effect of accounting estimates on our results of operations and financial condition, this MD&A should be read in conjunction with Gildan's unaudited condensed interim consolidated financial statements as at and for the three months ended March 29, 2026, and the related notes, and with our MD&A for the year ended December 28, 2025 (2025 Annual MD&A).

In preparing this MD&A, we have taken into account all information available to us up to April 29, 2026, the date of this MD&A. The unaudited condensed interim consolidated financial statements as at and for the three months ended March 29, 2026 and this MD&A were reviewed by Gildan's Audit and Finance Committee and were approved and authorized for issuance by our Board of Directors on April 29, 2026.

The unaudited condensed interim consolidated financial statements as at and for the three months ended March 29, 2026 have been prepared in accordance with generally accepted accounting principles ("GAAP"), more specifically, prepared in accordance with International Accounting Standard (IAS) 34, Interim Financial Reporting, as issued by the International Accounting Standards Board (IASB). All financial information contained in this MD&A is consistent with International Financial Reporting Standards (IFRS), except for certain information discussed in the section entitled "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

Additional information about Gildan, including our 2025 Annual Information Form, is available on our website at www.gildancorp.com, on the SEDAR+ website at www.sedarplus.ca, and on the EDGAR section of the U.S. Securities and Exchange Commission website (which includes the Annual Report on Form 40-F) at www.sec.gov.

**2.0 CAUTION REGARDING FORWARD-LOOKING STATEMENTS**

Certain statements included in this MD&A constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities legislation and regulations and are subject to important risks, uncertainties, and assumptions. This forward-looking information includes, amongst others, information with respect to our objectives and the strategies to achieve these objectives, including statements related to the Gildan's Sustainable Growth (GSG) strategy and Next Generation ESG strategy and ESG targets, the construction and development of the Company's second textile facility within the Bangladesh complex (including related timing and expenditures), the anticipated benefits of the acquisition of HanesBrands Inc. (now HanesBrands LLC, "HanesBrands" or "Hanes"), the HAA sale process, our deleveraging plan and expected reduction of our net debt to adjusted EBITDA leverage ratio, our planned capital expenditures during the next three years, and future return of capital to shareholders, including as it relates to dividends and share buybacks, as well as information with respect to our beliefs, plans, expectations, anticipations, estimates, and intentions. In particular, information appearing under the headings "Our business", "Strategy", "Operating results", "Liquidity and capital resources", "Financial risk management", and "Risks and uncertainties" contain forward looking statements. Forward-looking statements generally can be identified by the use of conditional or forward-looking terminology such as "may", "will", "expect", "intend", "estimate", "project", "assume", "anticipate", "plan", "foresee", "believe", or "continue", or the negatives of these terms or variations of them or similar terminology. We refer you to the Company's filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, as well as the risks described under the "Financial risk management", "Critical accounting estimates and judgments", and "Risks and uncertainties" sections of this MD&A for a discussion of the various factors that may affect the Company's future results. Material factors and assumptions that were applied in drawing a conclusion or making a forecast or projection are also set out throughout this document.

Forward-looking information is inherently uncertain and the results or events predicted in such forward-looking information may differ materially from actual results or events. Material factors, which could cause actual results or events to differ materially from a conclusion, forecast, or projection in such forward-looking information, include, but are not limited to:

QUARTERLY REPORT - Q1 2026 P.2

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in general economic, financial or geopolitical conditions globally or in one or more of the markets we serve;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to implement our growth strategies and plans, including our ability to bring projected capacity expansion online;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to successfully integrate acquisitions and realize expected benefits and synergies (including in respect of the acquisition of HanesBrands);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the intensity of competitive activity and our ability to compete effectively;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our reliance on a small number of significant customers, including our largest distributor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the fact that our customers do not commit to minimum quantity purchases;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to anticipate, identify, or react to changes in consumer preferences and trends;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to manage production and inventory levels effectively in relation to changes in customer demand;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• fluctuations and volatility in the prices of raw materials and energy related inputs (including as a result of the ongoing conflicts in the Middle East), from current levels, used to manufacture and transport our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our reliance on key suppliers and our ability to maintain an uninterrupted supply of raw materials, intermediate materials, and finished goods;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the success of our marketing, promotional, and innovation programs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our level of indebtedness and potential consequences thereof on our business and operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of climate, political, social, and economic risks, natural disasters, epidemics, pandemics and endemics, in the countries in which we operate or sell to, or from which we source production;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• disruption to manufacturing and distribution activities due to such factors as operational issues, disruptions in transportation logistic functions, labour disruptions, political or social instability, weather-related events, natural disasters, epidemics and pandemics, and other unforeseen adverse events;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• compliance with applicable trade, competition, taxation, environmental, health and safety, product liability, employment, patent and trademark, corporate and securities, licensing and permits, data privacy, bankruptcy, anti-corruption, and other laws and regulations in the jurisdictions in which we operate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the imposition of trade remedies, compliance with or changes to duties and tariffs, international trade legislation, bilateral and multilateral trade agreements and trade preference programs that the Company is currently relying on in conducting its manufacturing operations or the application of safeguards thereunder;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact, including broader economic impacts, of the tariffs imposed by the U.S. Administration and of any retaliation measures adopted by other governments, or the imposition of further restrictions or prohibitions on the export or import of goods between countries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• elimination of government subsidies and credits that we currently benefit from, and the non-realization of anticipated new subsidies and credits;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• factors or circumstances that could increase our effective income tax rate, including the outcome of any tax audits or changes to applicable tax laws or treaties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes to and failure to comply with environmental and health and safety regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impacts of global climate change on our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes to and failure to comply with consumer product safety laws and regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in our relationship with our employees or changes to domestic and foreign employment laws and regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our reliance on key management and our ability to attract and/or retain key personnel;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• negative publicity as a result of actual, alleged, or perceived violations of human rights, labour and environmental laws or international labour standards, or unethical labour or other business practices by the Company or one of its third-party contractors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to protect our intellectual property rights;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to protect the strength and reputation of our brands;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• operational problems with our information systems or those of our service providers as a result of system failures, viruses, security and cyber security breaches, disasters, and disruptions due to system upgrades or the integration of systems;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an actual or perceived breach of data security;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• rapid developments in artificial intelligence;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in accounting policies and estimates; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• exposure to risks arising from financial instruments, including credit risk on trade accounts receivables and other financial instruments, liquidity risk, foreign currency risk, and interest rate risk, as well as risks arising from commodity prices.

QUARTERLY REPORT - Q1 2026 P.3

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

These factors may cause the Company's actual performance and financial results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. Forward-looking statements do not take into account the effect that transactions or non-recurring or other special items announced or occurring after the statements are made may have on the Company's business. For example, they do not include the effect of business dispositions, acquisitions, other business transactions, asset write-downs, asset impairment losses, or other charges announced or occurring after forward-looking statements are made. The financial impact of such transactions and non-recurring and other special items can be complex and necessarily depends on the facts particular to each of them.

There can be no assurance that the expectations represented by our forward-looking statements will prove to be correct. The purpose of the forward-looking statements is to provide the reader with a description of management's expectations regarding the Company's future financial performance and may not be appropriate for other purposes. Furthermore, unless otherwise stated, the forward-looking statements contained in this report are made as of the date hereof, and we do not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events, or otherwise unless required by applicable legislation or regulation. The forward-looking statements contained in this report are expressly qualified by this cautionary statement.

**3.0 OUR BUSINESS**

**3.1 Overview**

Gildan is a leading vertically integrated manufacturer of everyday basic apparel, including activewear, underwear, hosiery and intimates products. Our products are sold to wholesale distributors, screenprinters, and embellishers globally, and to retailers in North America and internationally, including mass merchants, department stores, national chains, specialty retailers, craft stores, and online retailers, as well as directly to consumers. We also manufacture products for global lifestyle brand (GLB) companies who market these products under their own brands through their own retail establishments, e-commerce platforms, and/or to third-party retailers.

Manufacturing and operating as a socially responsible producer is at the heart of what we do. The vast majority of our sales are derived from products we manufacture ourselves. Since the Company's formation, we have made significant capital investments in developing and operating our own large-scale, vertically integrated manufacturing facilities, including yarn production, textile and sock manufacturing, as well as sewing operations, controlling all aspects of the production process from start to finish for the garments we produce.

We believe the skill set that we have developed in designing, constructing, and operating our own manufacturing facilities, the level of vertical integration of our supply chain and the capital investments that we have made over the years differentiate us from our competition who are not as vertically integrated and may rely more heavily on third-party suppliers. Owning and operating the vast majority of our manufacturing facilities allows us to exercise tighter control over our production processes, efficiency levels, costs and product quality, as well as to provide reliable service with short production and delivery cycle times. In addition, running our own operations allows us to achieve adherence to high standards for environmental and social responsibility practices employed throughout our supply chain.

QUARTERLY REPORT - Q1 2026 P.4

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**3.2 Our Operations**

**3.2.1 Brands, Products and Customers** 

The products we manufacture and sell are marketed under Company brands, including Gildan®, Hanes®, Comfort Colors®, American Apparel®, ALLPRO™, GOLDTOE®, Peds®, Bali®, Playtex®, Maidenform®, Bonds®, as well as Champion®, which is under an exclusive licensing agreement for the printwear channel in the U.S. and Canada, and Polo Ralph Lauren® also under a licensing agreement. Further, we manufacture for, and supply products to select leading global lifestyle brands, and to certain retail customers who market these products under their own exclusive brands.

Our primary products include activewear tops and bottoms, underwear tops and bottoms, socks (hosiery), and intimates. We sell our activewear products primarily in "blank" or undecorated form, without imprints or embellishment. The majority of the activewear products we sell are currently sold through the Wholesale channel, which includes wholesale distributors, screenprinters, embellishers and global lifestyle brand (GLB) customers. Wholesale distributors sell the blank garments to screenprinters/embellishers who decorate the products with designs and logos, and who in turn sell the embellished/imprinted activewear into a highly diversified range of end-use markets. These include educational institutions, athletic dealers, event merchandisers, promotional product distributors, charitable organizations, entertainment promoters, travel and tourism venues, and retailers. We also manufacture for and sell to select leading global athletic and lifestyle consumer brand companies who distribute these products within the retail channel through their own retail establishments, e-commerce platforms, and/or through third-party retailers. In addition to some activewear products, our widely recognized brand portfolio of underwear and socks for men, ladies and kids, bras, panties and shapewear is primarily sold through the Retail channel, encompassing large retailers both in North America and internationally, or directly to consumers. These retailers include mass merchants, department stores, national chains, sports specialty stores, food and drug retailers, dollar stores, and price clubs, all of which sell to consumers through their brick and mortar outlets and/or their e-commerce platforms. Additionally, we sell to pure-play online retailers who sell to consumers.

The following table summarizes our current primary product offering under Company and licensed brands:

---

| | | |
|:---|:---|:---|
| **Primary products** | **Product-line details** | **Brands**<sup>1</sup> |
| Activewear | T-shirts, fleece tops and bottoms, sport shirts, polos, tank tops and scrubs | Gildan®, Hanes®, Gildan Performance®, Gildan Hammer®, Gildan Softstyle®, Gildan® Heavy Cotton™, Gildan® Ultra Cotton®, Gildan DryBlend®, Gildan® HeavyBlend™, Comfort Colors®, American Apparel®, Champion®<sup>(2)</sup>, ALLPRO™, ComfortWash®, BEEFY®, Bonds® |
| Hosiery | athletic, dress, casual and workwear socks, liner socks, and socks for therapeutic purposes<sup>(3)</sup> | Gildan®, Hanes®, Gildan® Ultra Cotton®, GoldToe®, GoldToe® Signature™, GoldToe Edition<sup>TM</sup>, Peds®, MediPeds®, Powersox® |
| Underwear | men's and boys' underwear (tops and bottoms) and ladies panties | Gildan®, Hanes®, Gildan Platinum®, Gildan Softstyle®, Gildan Performance® BareSoft™, Gildan Performance® EZBreeze™, Bonds®, Berlei®, Bras N Things®, Polo Ralph Lauren®<sup>(4)</sup> |
| Intimates | women's lingerie, bras and shapewear | Bali®, Playtex®, WonderBra®, Maidenform®, Bonds®, Bras N Things®, Berlei® |

---

(1) As of the closing of the acquisition of HanesBrands, the Company classified HanesBrands' Australian business as discontinued operations. This includes the following brands: Bonds®, Bras N Things®, Berlei® and Sheridan®.

(2) Under an exclusive licensing agreement for the printwear channel in the U.S. and Canada.

(3) Applicable only to MediPeds®.

(4) Under an exclusive licensing agreement for the US, Canada, Mexico, and Japan.

QUARTERLY REPORT - Q1 2026 P.5

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**3.2.2 Manufacturing**

The vast majority of our products are manufactured in facilities that we own and operate. To a much lesser extent, we also use third-party contractors to supplement certain product requirements. Our vertically integrated operations span the garment production process from start to finish, encompassing capital-intensive yarn-spinning, textile and sock manufacturing facilities, as well as labour-intensive sewing facilities. Our manufacturing operations are situated in four main hubs, specifically in the United States, Central America, the Caribbean, and Asia. We also have manufacturing operations in South America. All of our yarn-spinning operations are located in the United States, while textile, sewing, and sock manufacturing operations are situated in the other geographical hubs mentioned above, the largest of which is in Honduras in Central America.

In order to support further sales growth, continue to drive an efficient and competitive cost structure, and enhance geographic diversification in our supply chain, we added substantial manufacturing capacity with a significant expansion in Bangladesh, which involved the development of a large multi-plant manufacturing complex expected to house two large textile facilities and related sewing operations. The construction of the first textile and sewing complex was completed and fully ramped-up as of the second quarter of 2025. In February 2026, the Company announced plans to construct and develop its second textile facility within the Bangladesh complex (Phase 2). Initial production at the facility is expected to start in the latter part of 2027. The infrastructure is currently in place to support this expansion, with the required capital expenditure expected to fit within the Company's current budget and plans.

The following table provides a summary of our primary manufacturing operations by geographic region:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **North America** | **Central America** | **South America** | **Caribbean** | **Asia**<sup>4</sup> |
| **Yarn-spinning facilities**<sup>(1)</sup>**:** <br>conversion of cotton, polyester and other fibres into yarn | ■ United States<br>&nbsp;&nbsp;&nbsp;&nbsp;(6 facilities) |  |  |  |  |
| **Textile facilities:** <br>knitting yarn into fabric, dyeing and cutting fabric  |  | ■ Honduras<br> (4 facilities)<br>■ El Salvador | ■ Brazil | ■ Dominican <br> Republic<br> (2 facilities) | ■ Bangladesh (2 facilities) |
| **Sewing facilities**<sup>(2)</sup>**:** <br>conversion of fabric into garments | ■ Mexico | ■ Honduras<br> (2 facilities)<br>■ Nicaragua <br> (5 facilities)<br>■ El Salvador<br> (2 facilities) | ■ Brazil<br>■ Argentina | &nbsp;&nbsp;&nbsp;■ Dominican <br>&nbsp;&nbsp;&nbsp;&nbsp;Republic <br>(5 facilities) | ■ Bangladesh (3 facilities)<br>■ Vietnam<br>(2 facilities)<br>■ Indonesia |
| **Garment-dyeing**<sup>(3)</sup>**:**<br>pigment dyeing or reactive dyeing process (Pigment Pure™) |  | ■ Honduras |  |  |  |
| **Hosiery manufacturing facilities:**<br>conversion of yarn into finished socks |  | ■ Honduras<br>■ El Salvador |  |  |  |

---

(1) While the majority of our yarn requirements are internally produced, we also use third-party yarn-spinning suppliers, primarily in Asia for our Bangladesh operations, to satisfy the remainder of our yarn needs. The majority of cotton used by our Asian contractors is U.S. cotton.

(2) Although the majority of our sewing facilities are Company-operated, we also use the services of third-party sewing contractors, primarily in Central America and Haiti, to satisfy the remainder of our sewing requirements.

(3) Garment dyeing is a feature of our Comfort Colors® products only, a proprietary dyeing process under the name Pigment Pure™ which involves a different dyeing process than how we typically dye the majority of our products at our textile facilities.

(4) As of the closing of the acquisition of HanesBrands, the Company classified HanesBrands' Australian business and its associated manufacturing facility in Indonesia as assets held for sale and discontinued operations.

**3.2.3 Sales, marketing and distribution**

Our global sales and marketing office is located in Christ Church, Barbados, where we have established customer related functions, including sales management, marketing, customer service, credit management, sales forecasting, production planning, inventory control, and logistics, as well as finance, human resources and information technology functions. Following the HanesBrands acquisition, we also maintain a significant presence in the United States which houses various sales, marketing and corporate business functions. We have established extensive distribution operations primarily through internally managed and operated large distribution centers across the Americas and other geographical locations where we manufacture and sell our products, including in Bangladesh and Australia. To supplement some of our distribution needs, we also use third-party warehouses in North America and Europe.

QUARTERLY REPORT - Q1 2026 P.6

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**3.2.4 Employees and corporate office**

We currently employ approximately 75,000 employees worldwide. Our corporate head office is located in Montreal, Canada.

**3.3 Competitive environment**

Competition in the basic apparel market is generally based upon service and product availability, price, quality, comfort and fit, style, and brand. We compete on these factors by leveraging our competitive strengths, including our strategically located and vertically integrated manufacturing supply chain, scale, cost structure, global distribution, and our brand positioning in the markets we serve. We believe our manufacturing skill set, together with our large-scale, low-cost vertically integrated supply chain infrastructure which we have developed through significant investments over time, are key competitive strengths and differentiators from our competition.

We compete with large and smaller U.S. based and foreign manufacturers or suppliers of basic family apparel. Among the competing North American-based manufacturers is Fruit of the Loom, Inc., a subsidiary of Berkshire Hathaway Inc., which competes through its own brand offerings and those of its subsidiary, Russell Corporation, depending on the channel. These companies manufacture in some of the same geographies as Gildan and generally compete within the same basic apparel product categories in similar channels of distribution in North America and international markets. In socks, underwear and intimates, our competitors also include Renfro Corporation, Jockey International, Inc., Kayser Roth Corporation, Victoria's Secret and SKIMS. In addition, we compete with smaller U.S. based companies selling to or operating as wholesale distributors of imprintables activewear products, including Next Level Apparel, Color Image Apparel, Inc. (owner of the Bella + Canvas brand), as well as Central American, Mexican and Asian manufacturers that supply products in the imprintables channel. Although we also compete with some of our customers' own private brand offerings, we also supply products to certain customers that are seeking strategic suppliers with our manufacturing capabilities to support their private brand offerings.

**3.4 Recent events**

***U.S. administration reciprocal tariffs announced***

The Company experienced significant uncertainty during 2025 regarding the timing, volatility, level and duration of country-specific tariffs imposed by the U.S. Administration. On August 7, 2025, the U.S. Administration introduced reciprocal tariffs that applied at varying country-specific rates, including 18% on Nicaragua, 20% on Vietnam, 20% on Bangladesh and 25% on India, with India also subject to an additional 25% secondary tariff. The additional secondary tariff on Indian goods was ultimately lifted on February 7, 2026. Certain countries, including El Salvador, Guatemala, Bangladesh, Vietnam, Indonesia and India, negotiated framework agreements establishing agreed-upon tariff rates, while countries not assigned or agreeing to a specific rate were generally subject to a 10% reciprocal tariff. These measures applied in addition to ordinarily applicable tariffs, although they did not apply to the value of qualifying U.S.-origin content when applicable requirements were satisfied.

On February 20, 2026, the Supreme Court of the United States invalidated the U.S. Administration's tariff measures imposed under the International Emergency Economic Powers Act ("IEEPA"), eliminating the legal basis for continued collection of those duties, including as applied to imports from countries party to the Dominican Republic–Central America Free Trade Agreement ("CAFTA-DR"). Subsequent rulings by the U.S. Court of International Trade ("CIT") have stated that such duties should be refunded, including for entries that were previously considered final, although whether importers will ultimately be entitled to refunds on previously paid tariffs remains uncertain and potentially subject to further legal proceedings, and the timing, process and recognition for any such refund remains subject to guidance from U.S. Customs and Border Protection ("CBP"). In response, the U.S. Administration indicated that, notwithstanding the Court's ruling, it intends to pursue alternative statutory mechanisms to impose tariffs, including a temporary 10% ad valorem duty under Section 122 of the Trade Act of 1974 for a period of 150 days beginning February 24, 2026. This duty applies broadly to imports but excludes goods qualifying for duty-free treatment under certain free trade agreements, including CAFTA-DR and United-States-Mexico-Canada Agreement (USMCA). As a result, a significant portion of the Company's imports that qualify under the CAFTA-DR program are not subject to the Section 122 measure.

While recent administrative guidance has provided certain clarity regarding the timing and application of the revised tariff framework, including effective dates and withdrawal treatment for goods entered or admitted into foreign-trade zones, the level and structure of tariffs, and their effects, remain uncertain and difficult to predict. The invalidation of the IEEPA measures and the resulting clarification of the applicable tariff regime are currently expected to reduce overall tariff exposure relative to prior periods, although such reduction may be partially offset by replacement measures.

QUARTERLY REPORT - Q1 2026 P.7

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

On February 21, 2026, the U.S. Administration publicly stated that it would raise such global tariffs from 10% to 15%, the maximum allowable rate under Section 122 of the Trade Act of 1974, although this higher rate had not yet been formally implemented as of the date hereof. While the U.S. Supreme Court's decision removes IEEPA as a legal basis for tariff collection going forward, other tariff programs and authorities remain in effect and continue to present potential cost and supply-chain impacts for the Company.

In addition, the U.S. Administration has initiated investigations under Section 301 of the Trade Act of 1974 targeting forced labor practices and structural overcapacity across multiple economies. These investigations may result in the imposition of new tariffs or import restrictions on a country- or product-specific basis. The scope, timing and magnitude of any such measures remain uncertain but could materially affect sourcing costs and supply chain decisions.

In summary, the principal U.S. tariff rates which are currently in effect and most relevant to our business and the apparel industry are the following:

• A temporary 10% ad valorem tariff imposed under Section 122 of the Trade Act of 1974, subject to applicable exclusions and currently scheduled to remain in effect for 150 days from February 24, 2026, unless modified

• Additional duties that remain applicable under other existing trade programs, where relevant, including Section 301 tariffs on certain products from China

• Other ordinarily applicable customs duties, including most-favored-nation (MFN) rates and applicable trade remedy measures

The Company is also evaluating the potential for refunds of certain IEEPA amounts previously tendered on entries that remain unliquidated or otherwise subject to administrative review. Based on recent judicial developments, current expectations are that refunds should be available across a broad range of entries; however, whether importers will ultimately be entitled to refunds on previously paid tariffs remains uncertain and potentially subject to further legal proceedings, and the timing, process and recognition of any such refunds remain subject to CBP implementation and further administrative guidance.

Such tariffs create uncertainty for our business. It remains difficult to predict whether, when and how existing trade measures may be modified, extended or replaced, particularly in light of the evolving global trade and geopolitical environment and ongoing negotiations between the United States and various trading partners. The U.S. Administration has publicly indicated that additional measures could be considered, including adjustments to currently applicable rates. The scope, timing and potential application of any such measures remain uncertain, and accordingly the Company cannot reasonably estimate the potential impact, if any, on its business at this time.

The Company's products from certain countries continue to qualify under various free trade agreements or programs, including CAFTA-DR, that provide for duty-free treatment when applicable requirements are satisfied. With respect to tariffs on imports from China and India, the Company has limited exposure to sourcing from these countries.

The Company has and will continue to monitor the international trade environment and actively explore mitigation strategies with a view to adapting its business and operations as necessary. The Company believes that its vertically integrated low-cost manufacturing operations position it well and provides flexibility to navigate tariff developments announced thus far. However, the situation has been characterized by dynamic and important evolution and therefore remains difficult to predict. While the Company currently expects to be able to largely mitigate the impacts of the reciprocal and other tariffs announced to date through various means, including but not limited to supply chain flexibility and pricing action, there can be no assurance that such mitigation strategies will be effective and offset, in whole or in part, the impact of the tariffs on our business. See our risk factor disclosure regarding international trade agreements and international trade regulations in section 15.0 of our 2025 annual MD&A "Risks and Uncertainties" as well as section 2.0 of this MD&A "Caution Regarding Forward-Looking Statements".

In addition, the Company continues to monitor the situation in Middle East region and related impact on the global energy markets and international shipping, including the closure of the Strait of Hormuz. See our risk factor disclosure in section 14.0 of this MD&A "Risks and Uncertainties".

QUARTERLY REPORT - Q1 2026 P.8

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**4.0 STRATEGY**

In 2022, Gildan launched its "Gildan Sustainable Growth" (GSG) strategy, which has since driven top and bottom-line growth, supported by three pillars: capacity expansion, innovation, and ESG. Over the past few years, we strengthened our vertically integrated model through initiatives such as acquiring and modernizing Frontier Yarns and completing the first phase of a major textile and sewing complex in Bangladesh. The construction of Bangladesh Phase 2 was announced in February 2026 with production expected to start in the latter part of 2027. We advanced innovation by introducing proprietary cotton technology, new product lines like Light Cotton™ and Softstyle™ Midweight Fleece, and Plasma Print Technology to enhance print quality and efficiency. Gildan is also actively investing in digital tools, predictive analytics, and artificial intelligence to accelerate decision-making across the organization, streamline processes, and optimize supply chain planning.

Gildan's acquisition of HanesBrands creates a global leader in basic apparel, expanding the Company's scale and diversifying its portfolio with HanesBrands' iconic innerwear brands, while leveraging Gildan's low-cost, vertically integrated manufacturing model. Furthermore, the acquisition enhances market reach across retail and wholesale while strengthening our innovation capabilities.

In 2026, Gildan embarked on its fifth year of implementing its Next Generation ESG strategy, which encompasses a broad range of initiatives. These include reducing carbon footprint and water intensity, fostering a circular economy, supporting regional economic development, ensuring respect for human rights, and maintaining safety standards throughout the supply chain. This strategy includes targets focused on five different pillars: Climate Energy and Water; Circularity; Human Capital Management; Long Term Value Creation; and Transparency and Disclosure. For more detailed information regarding the process of these initiatives, please refer to Gildan's 2024 ESG report. Information in our 2024 ESG Report does not form part of and is not incorporated by reference in this MD&A.

**5.0 OPERATING RESULTS**

**5.1 Non-GAAP financial measures**

We use non-GAAP financial measures and ratios to assess our operating and financial performance, financial condition and leverage, and liquidity. Securities regulations require that companies caution readers that earnings and other measures adjusted to a basis other than IFRS do not have standardized meanings and are unlikely to be comparable to similar measures used by other companies. Accordingly, they should not be considered in isolation. In this MD&A we use the following non-GAAP financial measures (on a continuing operations basis): adjusted net earnings, adjusted earnings before income taxes, adjusted income tax expense, adjusted gross profit, adjusted SG&A expenses, adjusted operating income, adjusted EBITDA. We also use the following non-GAAP ratios (on a continuing operations basis): adjusted diluted EPS, adjusted effective income tax rate, adjusted gross margin, adjusted SG&A expenses as a percentage of net sales, and adjusted operating margin. These financial metrics are used to measure our performance and financial condition from one period to the next, which excludes the variation caused by certain adjustments that could potentially distort the analysis of trends in our operating and financial performance, and because we believe such measures provide meaningful information on the Company's operating and financial performance and financial condition. Excluding these items does not imply they are non-recurring. Free cash flow is a non-GAAP financial measure that is presented including both continuing and discontinued operations, as this best represents the measure of the Company's ability to pay off incurred debt to manage its capital structure. We also use non-GAAP financial measures which include both total debt and net debt (including assets and liabilities held for sale), net debt leverage ratio (including assets and liabilities held for sale and both continuing and discontinued operations), as well as working capital excluding assets and liabilities held for sale.

The non-GAAP financial measures and ratios used by the Company are presented on a continuing operations basis (unless otherwise noted) and therefore exclude the results from discontinued operations. Discontinued operations include the results from the HanesBrands Australia ("HAA") operations which have been classified as held for sale and reported as discontinued operations as of December 1, 2025, the date of closing of the Hanes acquisition. The change has no impact on the comparative periods and financial measures previously reported by the Company since the acquisition of HanesBrands was completed in the fourth quarter of 2025 and results from the HanesBrands operations were therefore not included in the Company's results in respect of prior interim periods.

QUARTERLY REPORT - Q1 2026 P.9

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

We refer the reader to section 15.0 entitled "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A for the definition and complete reconciliation of all non-GAAP financial measures used and presented by the Company to the most directly comparable IFRS measures.

**5.2 Summary of quarterly results - GAAP basis**

The table below sets forth certain summarized unaudited quarterly financial data for net sales, net earnings, net earnings per share (basic and diluted) and weighted average number of shares (basic and diluted), for the eight most recently completed quarters. This quarterly information is unaudited and has been prepared on a GAAP basis in accordance with IAS 34 of IFRS. The financial results for any quarter are not necessarily indicative of the results to be expected for any future period.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| For the three months ended <br>*(in $ millions, except share and per share amounts or otherwise indicated)* | **Q1 2026** | Q4 2025<sup>(2)</sup> | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| Net sales | **1165.9** | 1078.5 | 910.6 | 918.5 | 711.7 | 821.5 | 891.1 | 862.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net earnings (loss) from continuing operations | **(55.1)** | 51.2 | 120.2 | 137.9 | 84.7 | 132.3 | 131.5 | 58.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net earnings (loss) from discontinued operations | **(10.7)** | 4.9 |  |  |  |  |  |  |
| Total net earnings (loss) | **(65.8)** | 56.1 | 120.2 | 137.9 | 84.7 | 132.3 | 131.5 | 58.4 |
| Basic earnings (loss) per share: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | **(0.30)** | 0.32 | 0.81 | 0.91 | 0.56 | 0.86 | 0.82 | 0.35 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | **(0.06)** | 0.04 |  |  |  |  |  |  |
| &nbsp;&nbsp;Total<sup>(1)</sup> | **(0.36)** | 0.35 | 0.81 | 0.91 | 0.56 | 0.86 | 0.82 | 0.35 |
| Diluted earnings (loss) per share: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | **(0.30)** | 0.32 | 0.80 | 0.91 | 0.56 | 0.86 | 0.82 | 0.35 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | **(0.06)** | 0.04 |  |  |  |  |  |  |
| &nbsp;&nbsp;Total<sup>(1)</sup> | **(0.36)** | 0.35 | 0.80 | 0.91 | 0.56 | 0.86 | 0.82 | 0.35 |
| Weighted average number of shares outstanding *(in '000s)*: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | **185158** | 160155 | 149230 | 150762 | 151875 | 153975 | 160862 | 168005 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | **185158** | 160204 | 149283 | 150815 | 151990 | 154369 | 161027 | 168139 |

---

(1) Quarterly EPS may not add to year-to-date EPS due to rounding.

(2) Includes the results of Hanes since December 1, 2025.

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

**5.2.1 Seasonality and other factors affecting the variability of results and financial condition**

Our results of operations for interim and annual periods are impacted by the variability of certain factors, including, but not limited to, changes in end-use demand and customer demand, our customers' decisions to increase or decrease their inventory levels, changes in our sales mix, and fluctuations in selling prices and raw material costs. While our products are sold on a year-round basis, our business experiences seasonal changes in demand which result in quarterly fluctuations in operating results. Although certain products have seasonal demand peak periods, competitive dynamics may influence the timing of customer purchases causing seasonal trends to vary somewhat from year to year. Historically, demand for T-shirts is lowest in the fourth quarter and highest in the second quarter of the year, when distributors purchase inventory for the peak summer selling season. Historically, demand for fleece is typically highest in advance of the fall and winter seasons, in the second and third quarters of the year. Sales of hosiery and underwear are typically higher during the second half of the year, during the back-to-school period and the Christmas holiday selling season. These seasonal sales trends also result in fluctuations in our inventory levels throughout the year.

QUARTERLY REPORT - Q1 2026 P.10

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

Our results are also impacted by fluctuations in the price of raw materials and other input costs. Cotton and polyester fibers are the primary raw materials used in the manufacture of our products, and we also use chemicals, dyestuffs, and trims, which we purchase from a variety of suppliers. Cotton prices are affected by consumer demand and global supply, which may be impacted by weather conditions in any given year, speculation on the commodities market, the relative valuations and fluctuations of the currencies of producer versus consumer countries, and other factors that are generally unpredictable. While we enter into purchase contracts and derivative financial instruments in advance of delivery to establish firm prices for the cotton component of our yarn requirements, our realized cotton costs can fluctuate significantly between interim and annual reporting periods. Energy costs in our results of operations are also affected by fluctuations in crude oil, natural gas, and petroleum prices, which can also influence transportation costs and the cost of related items used in our business, such as polyester fibers, chemicals, dyestuffs, and trims. Changes in raw material costs are initially reflected in the cost of inventory and only impact net earnings when the respective inventories are sold.

Business acquisitions may affect the comparability of results. In addition, management decisions to consolidate or reorganize operations, including the closure of facilities, may result in significant restructuring costs in an interim or annual period, as well as other significant costs relating thereto such as financing costs. Subsection 5.4.4 entitled "Restructuring and acquisition-related costs" in this MD&A contains a discussion of costs related to the Company's restructuring actions and business acquisitions. The issuance of additional shares as consideration for the Hanes acquisition resulted in a significant increase in the total number of shares outstanding which contributed to lower net earnings (loss) per share (EPS). This increase in shares outstanding was partially offset by share repurchases made until August 8, 2025, which reduced the number of shares outstanding, and contributed to higher net earnings (loss) per share (EPS) than would have otherwise been the case. The effect of asset write-downs, including allowances for expected credit losses, provisions for discontinued inventories, and impairments of long-lived assets can also affect the variability of our results. Our results of operations over the past ten quarters have been impacted by higher than usual SG&A expenses, due to costs relating to proxy contest and leadership changes and related matters (Q4 2023: $6.3 million, Q1 2024: $19.6 million, Q2 2024: $57.2 million, Q3 2024: $5.5 million, Q4 2024: $0.4 million; Q1 2025: $0.9 million, Q2 2025: $1.1 million, Q3 2025: $0.2 million, Q4 2025: $0.6 million and Q1 2026: $0.8 million), as explained in sections 5.4.3 and 15.0 of this MD&A, partially offset by the favorable impact of Barbados jobs credit (Q4 2023 and Q1 2024: nil, Q2 2024: $17.2 million, Q3 2024: $6.8 million, Q4 2024: $17.8 million, Q1 2025: $8.1 million, Q2 2025: $11.6 million, Q3 2025: $12.2 million, Q4 2025: $13.9 million and Q1 2026: $11.4 million). Our results have also been impacted by the inventory fair value step-up cost recorded as part of the Hanes business acquisition (Q4 2025: $35.4 million and Q1 2026: $106.3 million), the bridge facility commitment fees of $9.3 million relating to charges incurred as a part of the financing arrangements related to the Hanes acquisition in Q3 2025, net interest expense incurred on bond issuance prior to Hanes transaction close of $2.9 million in Q4 2025, as well as gain on debt redemption, net of debt breakage fee of $3.5 million in Q4 2025 related to the Hanes acquisition, as well acquisition-related transaction and integration costs (Q4 2025: $59.5 million and Q1 2026: $17.1 million), severance and other related charges related to the Hanes acquisition (Q4 2025: $27.5 million and Q1 2026: $27.1 million), the write-off of equipment related to facility closures associated with the integration of Hanes (Q1 2026: $14.5M), and $19.8 million for settlement of outstanding HanesBrands share units related to closing of the Hanes acquisition in Q4 2025.

Our reported amounts for net sales, cost of sales, SG&A expenses, and financial expenses or income are impacted by fluctuations in certain foreign currencies versus the U.S. dollar as described in the "Financial risk management" section of this MD&A. The Company periodically uses derivative financial instruments to manage risks related to fluctuations in foreign exchange rates.

QUARTERLY REPORT - Q1 2026 P.11

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**5.3 Selected financial information**

---

| | | | |
|:---|:---|:---|:---|
| *(in $ millions, except per share amounts or otherwise indicated)* | **Three months ended** | **Three months ended** | **Three months ended** |
| *(in $ millions, except per share amounts or otherwise indicated)* | **Mar 29, 2026** | Mar 30, 2025 | Variation |
| *(in $ millions, except per share amounts or otherwise indicated)* | **Mar 29, 2026** | Mar 30, 2025 | $% |
| Net sales | **1165.9** | 711.7 | 63.8% |
| Gross profit | **278.4** | 221.9 | 25.4% |
| Adjusted gross profit<sup>(1)</sup> | **384.7** | 221.9 | 73.3% |
| SG&A expenses | **218.7** | 87.3 | n.m. |
| Adjusted SG&A expenses<sup>(1)</sup> | **217.8** | 86.5 | n.m. |
| Restructuring and acquisition-related costs | **61.0** | 5.0 | n.m. |
| Operating income (loss) | **(1.3)** | 129.6 | n.m. |
| Adjusted operating income<sup>(1)</sup> | **166.8** | 135.5 | 23.1% |
| Adjusted EBITDA<sup>(1)</sup> | **221.1** | 165.8 | 33.3% |
| Financial expenses | **66.7** | 29.9 | n.m. |
| Income tax expenses (recovery) | **(13.0)** | 15.1 | n.m. |
| Adjusted income tax expense<sup>(1)</sup> | **20.0** | 15.8 | 26.7% |
| Net earnings (loss) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | **(55.1)** | 84.7 | n.m. |
| &nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations (net of tax) | **(10.7)** |  | n.m. |
| &nbsp;&nbsp;&nbsp;Total net earnings (loss) | **(65.8)** | 84.7 | (177.7)% |
| Adjusted net earnings from continuing operations<sup>(1)</sup> | **80.1** | 89.8 | (10.9)% |
| Basic earnings (loss) per share |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | **(0.30)** | 0.56 | (153.6)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | **(0.06)** |  | n.m. |
| &nbsp;&nbsp;&nbsp;Total | **(0.36)** | 0.56 | (164.3)% |
| Diluted earnings (loss) per share |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | **(0.30)** | 0.56 | (153.6)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | **(0.06)** |  | n.m. |
| &nbsp;&nbsp;&nbsp;Total | **(0.36)** | 0.56 | (164.3)% |
| Adjusted diluted EPS from continuing operations<sup>(1)</sup> | **0.43** | 0.59 | (27.1)% |
| Gross margin<sup>(2)</sup> | **23.9%** | 31.2% | (7.3) pp |
| Adjusted gross margin<sup>(1)</sup> | **33.0%** | 31.2% | 1.8 pp |
| SG&A expenses as a percentage of net sales<sup>(3)</sup> | **18.8%** | 12.3% | 6.5 pp |
| Adjusted SG&A expenses as a percentage of net sales<sup>(1)</sup> | **18.7%** | 12.1% | 6.6 pp |
| Operating margin<sup>(4)</sup> | **(0.1)%** | 18.2% | (18.3) pp |
| Adjusted operating margin<sup>(1)</sup> | **14.3%** | 19.0% | (4.7) pp |

---

n.m. = not meaningful

n/a = not applicable

(1) This is a non-GAAP financial measure or ratio. See section 16.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

(2) Gross margin is defined as gross profit divided by net sales.

(3) SG&A as a percentage of sales is defined as SG&A divided by net sales.

(4) Operating margin is defined as operating income (loss) divided by net sales.

Certain minor rounding variances exist between the consolidated financial statements and this summary.

QUARTERLY REPORT - Q1 2026 P.12

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Mar 29, 2026** | Dec 28, 2025 | |
| | **Mar 29, 2026** | Dec 28, 2025 | Variation<br>$% |
| Total assets | **10473.2** | 10465.2 | 0.1% |
| Total non-current financial liabilities | **4265.1** | 3863.7 | 10.4% |
| Long-term debt (including current portion) | **4715.1** | 4313.7 | 9.3% |
| Net debt<sup>(1)</sup> | **4867.6** | 4417.1 | 10.2% |
| Quarterly cash dividend declared per common share | &nbsp;&nbsp;&nbsp;**0.249** | 0.226 | 10.2% |
| Net debt leverage ratio<sup>(1)</sup> | &nbsp;&nbsp;&nbsp;**3.3** | 3.0 | n/a |

---

n.m. = not meaningful

n/a = not applicable

(1) This is a non-GAAP financial measure or ratio. See section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

**5.4 Operating review** 

**5.4.1 Net sales**

As a result of the HanesBrands acquisition, the Company has implemented a realignment of its internal sales teams to more closely align with its go-to-market strategy. As a result, effective the first quarter of fiscal 2026, the Company has transitioned from disclosing net sales for Activewear and Innerwear to providing the same information on a Retail and Wholesale basis. Wholesale comprises sales to distributors, screenprinters, embellishers and global lifestyle brand (GLB) customers. Retail comprises sales to mass merchants, department stores, national chains, specialty retailers, online retailers and directly to consumers.

Net sales from continuing operations by channel were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| *(in $ millions, or otherwise indicated)* | **Mar 29,<br>2026** | Mar 30,<br>2025 | Variation |
| *(in $ millions, or otherwise indicated)* | **Mar 29,<br>2026** | Mar 30,<br>2025 | $% |
| Wholesale | **552.1** | 626.4 | (11.9)% |
| Retail | **613.9** | 85.3 | n.m. |
| Total net sales | **1166.0** | 711.7 | 63.8% |

---

The Company recasted comparative figures to conform to the current period's presentation.

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

Net sales from continuing operations were derived from customers located in the following geographic areas:

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| *(in $ millions, or otherwise indicated)* | **Mar 29,<br>2026** | Mar 30,<br>2025 | Variation |
| *(in $ millions, or otherwise indicated)* | **Mar 29,<br>2026** | Mar 30,<br>2025 | $% |
| United States | **1069.1** | 632.6 | 69.0% |
| Canada | **25.0** | 27.9 | (10.7)% |
| International | **71.9** | 51.2 | 40.5% |
| Total net sales | **1166.0** | 711.7 | 63.8% |

---

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

QUARTERLY REPORT - Q1 2026 P.13

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

Net sales from continuing operations were $1.17 billion, up 63.8% over the prior year, in line with guidance of approximately $1.15 billion. The year over year increase reflects the HanesBrands acquisition partially offset by integration initiatives undertaken to optimize our manufacturing footprint and accelerate synergy capture, and lower volumes stemming from our proactive inventory reduction across customer channels, which temporarily reduced sell-in, as previously communicated. Wholesale sales were $552 million compared to $626 million, down 11.9% versus the prior year due to the aforementioned proactive inventory reduction across our combined customer channels as well as the non-recurrence of preemptive buying ahead of tariffs in the comparable period last year. This was partially offset by pricing initiatives implemented to offset a portion of the impact from tariffs, the contribution of HanesBrands and favourable mix. We continued to see robust demand for Comfort Colors® and our new brands, such as Champion® (under a licensing agreement) and ALLPRO™, continue to gather momentum with our customers. Retail sales were $614 million, compared to $85 million in the prior year, primarily reflecting the acquisition of HanesBrands and higher selling prices. Albeit to a lower extent, Retail sales were also affected by the lower sell-in previously detailed and the non-recurrence of preemptive buying ahead of tariffs. Notwithstanding, our key underwear brands captured additional market share in the quarter.

**5.4.2 Gross profit/margin and adjusted gross profit/margin**

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| *(in $ millions, or otherwise indicated)* | **Mar 29,<br>2026** | Mar 30,<br>2025 | Variation |
| Gross profit | **278.4** | 221.9 | 56.4 |
| Adjustments for: |  |  |  |
| &nbsp;&nbsp;&nbsp;Inventory fair value step-up cost recorded as part of the Hanes business acquisition<sup>(1)</sup> | **106.3** |  | 106.3 |
| Adjusted gross profit<sup>(2)</sup> | **384.7** | 221.9 | 162.7 |
| Gross margin | **23.9%** | 31.2% | (7.3) pp |
| Adjusted Gross margin<sup>(2)</sup> | **33.0%** | 31.2% | 1.8 pp |

---

(1) See subsection entitled "Certain adjustments to non-GAAP measures" for additional information on adjustments in section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

(2) This is a non-GAAP financial measure or ratio. See section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

The increase in gross profit for the three months ended March 29, 2026 was driven by the acquisition of HanesBrands. Gross margin for the three months ended March 29, 2026 was 23.9% of net sales, versus 31.2% of net sales in the same period last year. Adjusting for an inventory fair value step-up charge of $106 million recorded as part of the HanesBrands acquisition, adjusted gross profit was $385 million, or 33.0% of net sales compared to 31.2% in the prior year. The 180 basis point improvement mainly reflects favorable pricing initiatives implemented to partially offset the impact from tariffs, the favorable contribution from HanesBrands and to a lesser extent lower raw material and manufacturing costs.

QUARTERLY REPORT - Q1 2026 P.14

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**5.4.3 Selling, general and administrative expenses (SG&A)**

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| *(in $ millions, or otherwise indicated)* | **Mar 29,<br>2026** | Mar 30,<br>2025 | Variation |
| SG&A expenses | **218.7** | 87.3 | 131.3 |
| Adjustment for: |  |  |  |
| &nbsp;&nbsp;&nbsp;Costs relating to proxy contest and leadership changes and related matters<sup>(1)</sup> | **(0.8)** | (0.9) | 0.1 |
| Adjusted SG&A expenses<sup>(2)</sup> | **217.9** | 86.4 | 131.5 |
| SG&A expenses as a percentage of net sales | **18.8%** | 12.3% | 6.5 pp |
| Adjusted SG&A expenses as a percentage of net sales<sup>(2)</sup> | **18.7%** | 12.1% | 6.6 pp |

---

(1) See subsection entitled "Certain adjustments to non-GAAP measures" for additional information on adjustments in section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

(2) This is a non-GAAP financial measure or ratio. See section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

For the three months ended March 29, 2026, SG&A expenses were $219 million compared to $87 million in the prior year. Adjusting for charges related to the proxy contest and leadership changes and related matters, adjusted SG&A expenses were $218 million, or 18.7% of net sales, compared to $86 million or 12.1% of net sales for the same period last year. The increase in adjusted SG&A in the quarter reflects the acquisition of HanesBrands, partially offset by synergies realized as part of the HanesBrands integration process.

**5.4.4 Restructuring and acquisition-related costs** 

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| *(in $ millions)* | **Mar 29,<br>2026** | Mar 30,<br>2025 | Variation |
| Employee termination and benefit costs | **27.1** |  | 27.1 |
| Exit, relocation and other costs | **1.7** | 2.7 | (1.0) |
| Net loss (gain) on disposal, and write-downs of property, plant and equipment (PP&E), right-of-use assets and computer software related to exit activities | **14.4** | 2.3 | 12.1 |
| Acquisition-related transaction and integration costs | **17.8** |  | 17.8 |
| Restructuring and acquisition-related costs | **61.0** | 5.0 | 56.0 |

---

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

Restructuring and acquisition-related costs for the three months ended March 29, 2026 primarily reflect expenses associated with the integration of Hanes. These costs include $27.1 million for severance and other related charges (including severance costs arising from the closure of a hosiery manufacturing facility in Honduras and a textile manufacturing facility in Bangladesh), and $14.5 million for the write-off of equipment related to these facility closures.

In addition, $12.9 million was incurred for other integration-related expenses, such as consulting and IT costs. The period also includes $2.2 million in transaction costs related to the sale of HAA, which is classified as a discontinued operation, $2.0 million in additional transaction costs, and $1.4 million in other exit and relocation costs associated with the closure of the hosiery manufacturing facility. The remaining $0.8 million relates to restructuring activities initiated in previous years. Restructuring and acquisition-related costs for the three months ended March 30, 2025, included $2.5 million for the closure of a U.S. yarn-spinning facility, and other charges including costs relating to

restructuring activities initiated in previous years.

Subsequent to the end of the first quarter, the Company undertook additional restructuring and integration initiatives. The costs associated with these new actions, including any related severance, facility closure, and integration expenses, will be recognized in the second quarter of fiscal 2026 in accordance with the Company's accounting policies and applicable accounting standards.

QUARTERLY REPORT - Q1 2026 P.15

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**5.4.5 Operating income and adjusted operating income**

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| *(in $ millions, or otherwise indicated)* | **Mar 29,<br>2026** | Mar 30,<br>2025 | Variation |
| Operating income | **(1.3)** | 129.6 | (130.9) |
| Adjustments for: |  |  |  |
| &nbsp;&nbsp;&nbsp;Restructuring and acquisition-related costs<sup>(1)</sup> | **61.0** | 5.0 | 56.0 |
| &nbsp;&nbsp;&nbsp;Inventory fair value step-up recorded as part of the Hanes business acquisition<sup>(1)</sup> | **106.3** |  | 106.3 |
| &nbsp;&nbsp;&nbsp;Costs relating to proxy contest and leadership changes and related matters<sup>(1)</sup> | **0.8** | 0.9 | (0.1) |
| Adjusted operating income<sup>(2)</sup> | **166.8** | 135.5 | 31.3 |
| Operating margin | **(0.1)%** | 18.2% | (18.3) pp |
| Adjusted operating margin<sup>(2)</sup> | **14.3%** | 19.0% | (4.7) pp |

---

(1) See subsection entitled "Certain adjustments to non-GAAP measures" for additional information on adjustments in section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

(2) This is a non-GAAP financial measure or ratio. See section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

For the three months ended March 29, 2026, the Company generated an operating loss of $1 million, or (0.1)% of net sales, compared to income of $130 million in the prior year. Adjusting for restructuring and acquisition-related charge and the inventory fair value step-up charge as part of the HanesBrands acquisition, as well as the costs relating to proxy contest and leadership changes and related matters, adjusted operating income was $167 million up $31 million year over year. Adjusted operating margin was 14.3% of net sales, down 470 basis points versus last year and ahead of guidance of approximately 12.9%. The year over year decrease in adjusted operating margin is mainly a reflection of the HanesBrands acquisition and HanesBrands' lower operating margins due to historically higher levels of SG&A relative to Gildan.

**5.4.6 Financial expenses, net**

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| *(in $ millions)* | **Mar 29,<br>2026** | Mar 30,<br>2025 | Variation |
| Interest expense on financial liabilities recorded at amortized cost | **52.4** | 24.0 | 28.4 |
| Bank and other financial charges | **9.8** | 5.5 | 4.3 |
| Interest accretion on discounted lease obligations | **3.7** | 1.5 | 2.2 |
| Interest accretion on discounted provisions | **0.1** |  | 0.1 |
| Foreign exchange (gain) loss | **0.6** | (1.2) | 1.8 |
| Financial expenses, net | **66.6** | 29.8 | 36.8 |

---

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

The increase in interest expense for the three months ended March 29, 2026 of $28 million, was mainly due to the impact of higher average borrowing levels related to the Hanes acquisition, partially offset by slightly lower effective interest rates on our long-term debt. The increase in bank and other financial charges was mainly due to higher fees incurred on our receivables sale program, due to higher volumes under this program, partially offset by lower variable rates. The increase in interest accretion on discounted lease obligations was mainly due to higher lease liabilities as a result of the Hanes acquisition. Foreign exchange gains and losses in both periods relate primarily to the revaluation of net monetary assets denominated in foreign currencies.

QUARTERLY REPORT - Q1 2026 P.16

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**5.4.7 Income taxes**

The Company's average effective income tax rate is calculated as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| *(in $ millions, or otherwise indicated)* | **Mar 29,<br>2026** | Mar 30,<br>2025 | Variation |
| Income tax (recovery) expense | **(13.0)** | 15.1 | (28.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments for: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax recovery relating to restructuring charges and other adjustments | **33.0** | 0.7 | 32.3 |
| Adjusted income tax expense<sup>(3)</sup> | **20.0** | 15.8 | 4.2 |
| Earnings (loss) from continuing operations before income taxes | **(68.0)** | 99.8 | (167.8) |
| Adjustments<sup>(1)(4)</sup> | **168.1** | 5.9 | 162.2 |
| Adjusted earnings from continuing operations before income taxes<sup>(3)</sup> | **100.1** | 105.7 | -5.6 |
| Average effective income tax rate<sup>(2)</sup> | **19.1%** | 15.1% | 4.0 pp |
| Adjusted effective income tax rate<sup>(3)</sup> | **20.0%** | 15.0% | 5.0 pp |

---

(1) See subsection entitled "Certain adjustments to non-GAAP measures" for additional information on adjustments in section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

(2) Average effective income tax rate is calculated as income tax expense divided by earnings from continuing operations before income taxes.

(3) Adjusted income tax expense and adjusted earnings from continuing operations before income tax are non-GAAP financial measures, and adjusted effective income tax rate is a non-GAAP ratio calculated as adjusted income tax expense divided by adjusted earnings from continuing operations before income taxes. See section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

(4) Adjustments for the three months ended March 29, 2026 of $168.1 million, mainly include $106.3 million for the inventory fair value step-up cost recorded as part of the Hanes business acquisition (income tax recovery of $26.9 million), $61 million for restructuring and acquisition-related costs (income tax recovery of $6.1 million), and costs relating to proxy contest and leadership changes and related matters of $0.8 million. Adjustments for the three months ended March 30, 2025 of $5.9 million, included costs relating to proxy contest and leadership changes and related matters and restructuring and acquisition-related costs.

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

The income tax recovery recognized for the three months ended March 29, 2026, compared to an income tax expense in the same period in 2025, reflects the tax benefit associated with restructuring charges and other adjustments recorded during the current period. Excluding these items, the increase in adjusted income tax expense is primarily attributable to a shift in the geographical distribution of the Company's pre-tax earnings following the acquisition of Hanes. Specifically, a significantly higher proportion of consolidated profits was generated in the United States during the quarter, which is subject to a higher tax rate relative to other jurisdictions in which the Company operates.

The increase in the effective income tax rate on a GAAP basis for the three months ended March 29, 2026 compared to the same period last year was mainly due to the acquisition of Hanes, as discussed above.

QUARTERLY REPORT - Q1 2026 P.17

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**5.5 Net earnings, adjusted net earnings, and earnings per share measures**

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| *(in $ millions, except per share amounts)* | **Mar 29,<br>2026** | Mar 30,<br>2025 | Variation |
| Net earnings (loss) from continuing operations | **(55.1)** | 84.7 | (139.7) |
| Adjustments for: |  |  |  |
| &nbsp;&nbsp;&nbsp;Restructuring and acquisition-related costs<sup>(1)</sup> | **61.0** | 5.0 | 56.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventory fair value step-up cost recorded as part of the Hanes business acquisition | **106.3** |  | 106.3 |
| &nbsp;&nbsp;&nbsp;Costs relating to proxy contest and leadership changes and related matters<sup>(1)</sup> | **0.8** | 0.9 | (0.1) |
| &nbsp;&nbsp;&nbsp;Income tax recovery relating to the above-noted adjustments | **(33.0)** | (0.7) | (32.3) |
| Adjusted net earnings from continuing operations<sup>(2)</sup> | **80.0** | 89.9 | (9.9) |
| Basic EPS (loss) from continuing operations | **(0.30)** | 0.56 | (0.86) |
| Diluted EPS (loss) from continuing operations | **(0.30)** | 0.56 | (0.86) |
| Adjusted diluted EPS from continuing operations<sup>(2)</sup> | **0.43** | 0.59 | (0.16) |

---

(1) See subsection entitled "Certain adjustments to non-GAAP measures" for additional information on adjustments in section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

(2) This is a non-GAAP financial measure or ratio. See section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

The decrease in GAAP net earnings from continuing operations for the three months ended March 29, 2026 compared to the same period last year was mainly due to the decrease in operating income and higher financial expenses. Adjusting for restructuring and acquisition-related costs, the inventory fair value step-up charge and an income tax recovery of $33 million related to restructuring charges and other adjustments, adjusted net earnings from continuing operations during the three months ended March 29, 2026 were $80 million compared to $90 million the same period in the prior year. Reflecting the lower net earnings and a higher outstanding share base as a result of the acquisition, GAAP diluted loss per share from continuing operations were $0.30, compared to GAAP diluted earnings per share of $0.56 in the prior year, and adjusted diluted earnings per share from continuing operations were $0.43, down 27.1% from $0.59 in the same period in the prior year.

QUARTERLY REPORT - Q1 2026 P.18

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**6.0 FINANCIAL CONDITION** 

**6.1 Current assets and current liabilities**

---

| | | | |
|:---|:---|:---|:---|
| *(in $ millions)* | **Mar 29, 2026** | Dec 28, 2025 | Variation |
| Cash and cash equivalents | **237.1** | 284.5 | (47.4) |
| Trade accounts receivable | **1009.7** | 955.7 | 54.0 |
| Inventories | **2417.7** | 2370.2 | 47.5 |
| Prepaid expenses, deposits and other current assets | **160.6** | 140.3 | 20.3 |
| Accounts payable and accrued liabilities | **(1051.2)** | (1264.2) | 213.0 |
| Income tax payable | **(85.4)** | (80.8) | (4.6) |
| Current portion of lease obligations | **(59.4)** | (59.8) | 0.3 |
| Current portion of long-term debt | **(450.0)** | (450.0) |  |
| Dividends payable | **(45.8)** |  | (45.8) |
| Total working capital<sup>(1)</sup> | **2133.3** | 1895.9 | 237.3 |
| Current ratio<sup>(2)</sup> | **2.3** | 2.0 | n.m. |

---

n.m. = not meaningful

(1) This is a non-GAAP financial measure or ratio. See section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

(2) Current ratio is defined as current assets (excluding assets held for sale) divided by current liabilities (excluding liabilities held for sale).

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The increase in trade accounts receivable (which are net of accrued sales discounts) was mainly due to the impact of higher sales in the first quarter of fiscal 2026 compared to the fourth quarter of fiscal 2025, lower sales of trade accounts receivables to financial institutions under receivables purchase agreements, seasonally lower offset for accruals for sales discounts compared to the end of fiscal 2025 mainly relating to the payout of annual rebate programs in the first quarter of fiscal 2026, and partially offset by higher days sales outstanding (DSO) as a result of longer payment terms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The increase in inventories was mainly due to higher finished goods inventories as a result of higher unit volumes, partially offset by lower average units costs mainly due to the impact of lower reciprocal tariffs and by the impact of the inventory fair value step-up cost of $106 million recognized in cost of sales in the first quarter of fiscal 2026 relating to the Hanes business acquisition.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The increase in prepaid expenses, deposits and other current assets is mainly due to higher fair value of derivative financial instrument assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The decrease in accounts payable and accrued liabilities was mainly due to the timing of remittances to banks of sold receivable collections, the impact of lower days payable outstanding, a decrease in the fair value of derivative financial instrument liabilities, and seasonally lower accruals for variable compensation, partially offset by higher accrued interest on outstanding debt.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Working capital was $2,133.3 million as at March 29, 2026, compared to $1,895.9 million as at December 28, 2025. The current ratio at the end of the first quarter of fiscal 2026 was 2.3, compared to 2.0 at the end of fiscal 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Assets and liabilities held for sale (excluded from working capital) were acquired as part of the Hanes acquisition and relate mainly to the businesses of HAA which have been classified as held for sale, as well as the assets and liabilities of the Champion Japan business which has been in a divestiture process since 2024. HAA has also been classified as a discontinued operation. Cost of sales included in earnings from discontinued operations for the three months ended March 29, 2026 includes a one-time $23 million of inventory fair value step-up cost.

QUARTERLY REPORT - Q1 2026 P.19

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**6.2 Property, plant and equipment, right-of-use assets, intangible assets, and goodwill**

---

| | | | | |
|:---|:---|:---|:---|:---|
| *(in $ millions)* | Property, plant<br>and equipment | Right-of-use <br>assets | Intangible<br>assets | Goodwill |
| Balance, December 28, 2025 | 1467.7 | 234.8 | 3021.4 | 868.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additions | 23.7 | 0.7 | 1.9 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;PPA adjustments | 2.3 |  | (2.8) | (29.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | (33.4) | (11.9) | (14.4) |  |
| &nbsp;&nbsp;&nbsp;Net carrying amounts of disposals and write-downs | (14.1) | (0.3) |  |  |
| **Balance, March 29, 2026** | **1446.2** | **223.3** | **3006.1** | **839.5** |

---

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The decrease in property, plant and equipment mainly reflects the impact of depreciation and write-downs of equipment related to facility closures, largely offset by capital expenditures related to textile and sewing manufacturing operations, as well as modernization of yarn facilities obtained through the acquisition of Frontier Yarns in December 2021.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The decrease in right-of-use assets mainly reflects the impact of depreciation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Intangible assets are comprised of customer contracts and relationships, trademarks, license agreements, and computer software. The decrease in intangible assets mainly reflects the amortization of $14.4 million, primarily related to customer relationships acquired as part of the Hanes acquisition.

**6.3 Other non-current assets and non-current liabilities**

---

| | | | |
|:---|:---|:---|:---|
| *(in $ millions)* | **Mar 29, 2026** | Dec 28, 2025 | Variation |
| Deferred income tax assets | **19.4** | 23.0 | (3.6) |
| Other non-current assets | **128.8** | 139.7 | (10.9) |
| Long-term debt | **(4265.1)** | (3863.7) | (401.4) |
| Lease obligations | **(237.2)** | (254.7) | 17.5 |
| Deferred income tax liabilities | **(374.6)** | (401.1) | 26.5 |
| Employee benefit obligations | **(108.7)** | (118.4) | 9.7 |
| Other non-current liabilities | **(29.1)** | (29.4) | 0.3 |

---

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The decrease in other non-current assets is mainly due to a decrease in the fair value of derivative financial instrument assets, partially offset by higher jobs credits receivable (refer to note 9f) of the unaudited interim consolidated financial statements).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• See section 8.0 of this MD&A entitled "Liquidity and capital resources" and subsection 7.4 of this MD&A entitled "Cash flows from (used in) financing activities", for the discussion on long-term debt.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The change in lease obligations mainly reflects payments made during the three months ended March 29, 2026

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The net decrease in deferred income tax liabilities relates mainly to the tax impacts of the inventory fair value step-up cost recorded during the first quarter of fiscal 2026, which is related to the deferred tax liabilities recorded as part of the Hanes acquisition.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Other non-current liabilities include provisions, employee benefit obligations and certain derivative financial instrument liabilities.

QUARTERLY REPORT - Q1 2026 P.20

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**7.0 CASH FLOWS** 

The cash flows related to discontinued operations have not been segregated. Accordingly, the cash flows provided below include the results of continuing and discontinued operations.

**7.1 Cash flows from (used in) operating activities**

---

| | | | |
|:---|:---|:---|:---|
|  | **Three months ended** | **Three months ended** | **Three months ended** |
| *(in $ millions)* | **Mar 29,<br>2026** | Mar 30,<br>2025 | Variation |
| Net earnings (loss) | **(65.8)** | 84.7 | (150.5) |
|  Adjustments for: |  |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | **54.2** | 30.3 | 23.9 |
| &nbsp;&nbsp;&nbsp;Loss (gain) on disposal of PP&E and right-of-use assets | **0.1** | (0.1) | 0.2 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | **(24.5)** | (1.1) | (23.4) |
| &nbsp;&nbsp;&nbsp;Share-based compensation | **12.6** | 8.9 | 3.7 |
| &nbsp;&nbsp;&nbsp;Other | **(1.5)** | 0.5 | (2.0) |
| Changes in non-cash working capital balances | **(254.5)** | (265.5) | 11.0 |
| Cash flows from (used in) operating activities | **(279.4)** | (142.3) | (137.1) |

---

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash flows used in operating activities were $279 million for the three months ended March 29, 2026, compared to cash flows used in operating activities of $142 million in the corresponding period last year. The increase was mainly due to the impact of lower net earnings, partially offset by a lower increase in non-cash working capital.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-cash working capital increased by $255 million during the three months ended March 29, 2026, compared to an increase of $266 million during the three months ended March 30, 2025. The lower increase was mainly due to a higher decrease in accounts payable and accrued liabilities, largely offset by a lower increase in inventories and trade accounts receivable. See section 6.1 "Current assets and current liabilities" for additional explanations on the variances between December 28, 2025 and March 29, 2026 impacting non-cash working capital.

QUARTERLY REPORT - Q1 2026 P.21

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**7.2 Cash flows from (used in) investing activities**

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| *(in $ millions)* | **Mar 29,<br>2026** | Mar 30,<br>2025 | Variation |
| Purchase of property, plant and equipment | **(28.7)** | (22.3) | (6.4) |
| Purchase of intangible assets | **(1.6)** | (1.0) | (0.6) |
| Proceeds from sale and leaseback, disposal of assets held for sale and other disposals of PP&E | **(0.1)** |  | (0.1) |
| Cash flows from (used in) investing activities | **(30.4)** | (23.3) | (7.1) |

---

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash flows used in investing activities were $30 million for the three months ended March 29, 2026, compared to cash flows used in investing activities of $23 million in the corresponding period last year. The change was mainly due to slightly higher capital expenditures in 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Capital expenditures<sup>1</sup> for the three months ended March 29, 2026 are described in section 6.2 of this MD&A entitled "Property, plant and equipment, right-of-use assets, intangible assets, and goodwill".

**7.3 Free cash flow**

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| *(in $ millions)* | **Mar 29,<br>2026** | Mar 30,<br>2025 | Variation |
| Cash flows from (used in) operating activities | **(279.5)** | (142.2) | (137.3) |
| Cash flows from (used in) investing activities | **(30.4)** | (23.3) | (7.1) |
| Adjustment for: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Business acquisitions | **—** |  |  |
| Free cash flow<sup>(1)</sup> | **(309.9)** | (165.5) | (144.4) |

---

(1) This is a non-GAAP financial measure or ratio. See section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The year over year decrease in free cash flow of $144 million for the three months ended March 29, 2026 was mainly due to a $137 million decrease in operating cash flows, which was largely in line with the Company's expectations, as well as slightly higher cash flows used in investing activities (as explained in section 7.2. of this MD&A entitled "Cash flows from (used in) investing activities").

(1) Capital expenditures include purchases of property, plant and equipment and intangible assets.

QUARTERLY REPORT - Q1 2026 P.22

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**7.4 Cash flows from (used in) financing activities**

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| *(in $ millions)* | **Mar 29,<br>2026** | Mar 30,<br>2025 | Variation |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase in amounts drawn under long-term bank credit facility | **415.0** | 75.0 | 340.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of Senior unsecured notes | **—** | 486.3 | (486.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayment of delayed draw term loan | **—** | (300.0) | 300.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share repurchases for settlement of non-Treasury RSUs | **(71.5)** | (25.8) | (45.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;Repurchase and cancellation of shares | **—** | (61.6) | 61.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Withholding taxes paid pursuant to the settlement of non-Treasury RSUs | **(52.1)** | (21.2) | (30.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;Payment of lease obligations | **(22.9)** | (4.4) | (18.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | **(3.3)** | (6.1) | 2.8 |
| Cash flows from (used in) financing activities: | **265.2** | 142.2 | 123.0 |

---

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash flows from financing activities for the three months ended March 29, 2026 of $265 million were mainly related to net cash inflows relating to long-term debt, partially offset by funds used for the settlement of the stock-based awards vesting during the quarter, and for the payment of lease obligations. Cash flows from financing activities for the three months ended March 30, 2025 of $142 million were mainly related to net cash inflows relating to long-term debt, partially offset from the repurchase and cancellation of common shares under the NCIB programs as discussed in section 8.7 of this MD&A, and funds used for the settlement of the stock-based awards vesting during the quarter.

**8.0 LIQUIDITY AND CAPITAL RESOURCES**

**8.1 Capital allocation framework**

Historically, our primary uses of funds have been for working capital requirements, capital expenditures, business acquisitions, and the payment of dividends and share repurchases, which we have funded with cash generated from operations and with funds drawn from our long-term debt facilities. We have established a capital allocation framework intended to enhance sales and earnings growth as well as shareholder returns. After funding working capital needs, our first priority of cash use is to fund our organic growth with the required capital investments. Beyond these requirements, our next priorities for capital allocation are to support our dividends and for opportunistic complementary acquisitions with a preference towards opportunities that could enhance our supply chain model. In addition, we have used excess cash to repurchase shares under normal course issuer bid programs.

The Company has set a net debt leverage target ratio<sup>2</sup> of 1.5 to 2.5 times pro-forma adjusted EBITDA for the trailing twelve months, which it believes will provide an efficient capital structure and a framework within which it can execute on its capital allocation priorities. As a result of the closing of the Hanes acquisition, our net debt leverage ratio exceeds our stated target range. Accordingly, we paused our share repurchases starting in August 2025, and we expect share repurchases to resume when our net debt leverage ratio approximates the midpoint of the target range. We expect that cash flows from operating activities and the unutilized financing capacity under our long-term debt facilities, will continue to provide us with sufficient liquidity to fund our organic growth strategy, including anticipated working capital requirements and projected capital expenditures (which are currently planned to be at levels close to 3%-4% of net sales per year, on average, for the next three years), as well as for returning capital to shareholders through dividends and when the net debt leverage ratio approximates the midpoint of the target range, share repurchases in line with our leverage framework and value considerations. Refer to note 28 of the audited annual consolidated financial statements for the year ended December 28, 2025 for a discussion on the Company's liquidity risk.

(2) This is a non-GAAP financial measure or ratio. See section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

QUARTERLY REPORT - Q1 2026 P.23

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**8.2 Long-term debt and net debt and net debt leverage ratio**

The Company's long-term debt as at March 29, 2026 is described below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Effective interest rate**<sup>(1)</sup> | **Principal amount** | **Principal amount** | **Maturity date** |
| *(in $ millions, or otherwise indicated)* | **Effective interest rate**<sup>(1)</sup> | **Mar 29, 2026** | Dec 28, 2025 | **Maturity date** |
| **Non-current portion of long-term debt** |  |  |  |  |
| Revolving long-term bank credit facility, interest at variable U.S. interest rate<sup>(2)(3)</sup> | **5.2%** | **655.0** | 240.0 | **Mar 2031** |
| Senior unsecured Canadian notes, Series 1, interest at fixed rate of 4.36%, payable semi-annually | **5.5%** | **360.8** | 365.6 | **Nov 2029** |
| Senior unsecured Canadian notes, Series 2, interest at fixed rate of 4.71%, payable semi-annually | **5.8%** | **144.3** | 146.2 | **Nov 2031** |
| Senior unsecured Canadian notes, Series 3, interest at CORRA plus 1.26%, payable quarterly | **5.1%** | **108.2** | 109.7 | **Mar 2028** |
| Senior unsecured Canadian notes, Series 4, interest at fixed rate of 3.630%, payable semi-annually | **5.4%** | **144.3** | 146.2 | **Mar 2028** |
| Senior unsecured Canadian notes, Series 5, interest at fixed rate of 4.149%, payable semi-annually | **5.6%** | **252.5** | 255.9 | **Nov 2030** |
| Senior unsecured U.S., Series 1, interest at fixed rate of 4.70%, payable semi-annually  | **4.7%** | **600.0** | 600.0 | **Oct 2030** |
| Senior unsecured U.S., Series 2, interest at fixed rate of 5.40%, payable semi-annually | **5.4%** | **600.0** | 600.0 | **Oct 2035** |
| Term loan, interest at variable U.S. interest rate, payable monthly<sup>(5)</sup> | **5.2%** | **300.0** | 300.0 | **Aug 2029** |
| Term loan, interest at variable U.S. interest rate, payable monthly<sup>(5)</sup> | **5.4%** | **600.0** | 600.0 | **Dec 2028** |
| Term loan, interest at variable U.S. interest rate, payable monthly<sup>(5)</sup> | **5.2%** | **500.0** | 500.0 | **Dec 2027** |
|  |  | **4265.1** | 3863.6 |  |
| **Current portion of long-term debt** |  |  |  |  |
| Notes payable, interest at fixed rate of 2.91%, payable semi-annually<sup>(6)</sup> | **2.9%** | **100.0** | 100.0 | **Aug 2026** |
| Notes payable, interest at Adjusted SOFR plus a spread of 1.57%, payable quarterly<sup>(6)(7)</sup> | **2.9%** | **50.0** | 50.0 | **Aug 2026** |
| Term loan, interest at variable U.S. interest rate, payable monthly<sup>(2)(4)</sup> | **4.8%** | **300.0** | 300.0 | **Jun 2026** |
|  |  | **450.0** | 450.0 |  |
| **Long-term debt (including current portion)** |  | **4715.1** | 4313.6 |  |

---

(1)Represents the annualized effective interest rate for the three months ended March 29, 2026, including the impact of interest rate swaps and cross currency interest rate swaps, where applicable.

(2)Secured Overnight Financing Rate (SOFR) advances plus a spread ranging from 1% to 3%.

(3)The Company's committed unsecured revolving long-term bank credit facility of $1.6 billion provides for an annual extension which is subject to the approval of the lenders. The spread added to the adjusted Term SOFR is a function of the Company's credit rating (as defined in the credit facility agreement and its amendments). In addition, an amount of $31.7 million (December 28, 2025 - $30.7 million) has been committed against this facility to cover various letters of credit.

(4)The unsecured term loan is non-revolving and can be prepaid in whole or in part at any time with no penalties. The spread added to the adjusted Term SOFR is a function of the total net debt to EBITDA ratio (as defined in the term loan agreements and its amendments). The term loan matures on June 30, 2026.

(5)The term loan facility can be prepaid in whole or in part at any time with no penalties. U.S. Base Rate Advances at U.S. Base rates or SOFR advances plus a spread ranging from 1% to 2% based on the Company's credit rating (as defined in the term loan agreements and its amendments).

(6)The unsecured notes issued to accredited investors in the U.S. private placement market can be prepaid in whole or in part at any time, subject to the payment of a prepayment penalty as provided for in the Note Purchase Agreement.

(7)Adjusted SOFR rate is determined on the basis of floating rate notes that bear interest at a floating rate plus a spread of 1.57%.

QUARTERLY REPORT - Q1 2026 P.24

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

The Series 1 Canadian notes and Series 2 Canadian notes have been hedged for foreign currency fluctuations through cross currency principal and interest rate swaps, which serves to lock in the combined principal at US$500 million and the interest at 5.49% and 5.765% respectively. Interest on these senior unsecured Canadian notes is payable semi-annually.

On March 13, 2025, the Company issued floating rate Series 3 senior unsecured notes ("Series 3 Canadian notes") with a principal amount of $150 million in Canadian dollars ($104 million in U.S. dollars), which will mature on March 13, 2028. The Series 3 floating rate notes were issued at par and bear interest at a rate equal to the daily compounded CORRA plus 1.26% annually. On the same date, the Company issued at par, 3.630% Series 4 senior unsecured notes ("Series 4 Canadian notes") with a principal amount of $200 million in Canadian dollars ($139 million in U.S. dollars), which will mature on March 13, 2028. Additionally, on the same date, the Company issued 4.149% Series 5 senior unsecured notes ("Series 5 Canadian notes") with a principal amount of $350 million in Canadian dollars ($243 million in U.S. dollars), which will mature on November 22, 2030. The notes were offered in Canada on a private placement basis.

The Series 3 Canadian notes have been hedged for foreign currency fluctuations through cross currency principal and interest rate swaps, which serves to lock in the principal at US$104 million and converts the interest payment to SOFR plus 1.405%.

The Series 4 Canadian notes have been hedged for foreign currency fluctuations through cross currency principal and interest rate swaps, which serves to lock in the principal at US$139 million. The Series 4 notes also have a fixed-to-floating interest rate swap to convert the fixed interest rate to SOFR plus 1.425%.

The Series 5 Canadian notes have been hedged for foreign currency fluctuations through cross currency principal and interest rate swaps, which serves to lock in the principal at US$243 million and the interest at 5.635%.

All of these hedging instruments relating to the Senior unsecured notes are for the same duration as the hedged note.

On August 13, 2025, the Company entered into a debt commitment letter providing for certain debt financing, the proceeds of which were expected to be used, to fund the cash portion of the consideration for the Hanes acquisition, repay certain of Hanes' existing indebtedness and pay expenses incurred in connection with the acquisition. The financing was initially comprised of a bridge facility in an aggregate principal amount of $1.2 billion and term loans in an aggregate principal amount of $1.1 billion, consisting of a $500 million 2-year term loan and a $600 million 3-year term loan (the "New Term Loan Facility"). On September 10, 2025, the Company entered into a joinder to the debt commitment letter pursuant to which a portion of the commitments in respect of the bridge facility and New Term Loan Facility were syndicated to certain other financial institutions. The bridge facility commitment was subsequently terminated in the fourth quarter of 2025 upon closing of the offering by the Company of $1.2 billion aggregate principal amount of senior unsecured notes as described below.

On October 7, 2025, the Company issued 4.700% Series 1 U.S. senior unsecured notes ("Series 1 U.S. notes") with a principal amount of $600 million, which will mature on October 7, 2030. Additionally, on the same date, the Company issued 5.400% Series 2 U.S. senior unsecured notes ("Series 2 U.S. notes") with a principal amount of $600 million, which will mature on October 7, 2035. The notes were offered in the United States on a private placement basis.

On December 1, 2025, the Company entered into an unsecured committed 2-year term loan agreement for a total principal amount of $500 million and an unsecured committed 3-year term loan agreement for a total principal amount of $600 million, under the New Term Loan Facility. In the event of a sale of HAA, the net proceeds from such disposition will be required to be used to repay indebtedness under this facility in accordance with its terms.

The New Term Loan Facility is non-revolving and bears interest, at the Company's option, at Term SOFR plus a 0.10% adjustment plus an applicable margin of approximately 1.45% for the 2-year term loan and 1.58%, for the 3-year term loan, which applicable margin varies depending on the Company's public debt ratings (as defined in the term loan agreement). The 2-year term loan will mature two years after closing of the New Term Loan Facility on December 1, 2027 and the 3-year term loan will mature three years after closing of the New Term Loan Facility on December 1, 2028. The term loans include covenants substantially similar to those under Gildan's existing credit agreements.

QUARTERLY REPORT - Q1 2026 P.25

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

On September 16, 2025, the Company amended its unsecured revolving long-term bank credit facility to increase the aggregate revolving commitments from $1 billion to $1.2 billion for effectiveness on December 1, 2025.

On March 20, 2026 the Company amended its unsecured revolving long-term bank credit facility to increase the aggregate revolving commitments from $1.2 billion to $1.6 billion, effective the same date.

Under the terms of the revolving facility, term loan facilities and U.S. private notes, the Company is required to comply with certain covenants, including maintenance of financial ratios. The Company was in compliance with all financial covenants at March 29, 2026. The Company expects to maintain compliance with its covenants over the next twelve months, based on its current expectations and forecasts.

---

| | | |
|:---|:---|:---|
| *(in $ millions)* | **Mar 29, 2026** | Dec 28, 2025 |
| Long-term debt (including current portion) | **4715.1** | 4313.7 |
| Bank indebtedness | **—** |  |
| Foreign currency component of derivative financial instrument on Canadian Senior unsecured notes | **(23.8)** | (37.4) |
| Lease obligations (including current portion) | **296.7** | 314.5 |
| Lease obligations (including current portion) included in liabilities held for sale | **131.2** | 121.3 |
| Total debt<sup>(1)</sup> | **5119.2** | 4712.1 |
| Cash and cash equivalents | **(237.1)** | (284.5) |
| Cash and cash equivalents included in assets held for sale | **(14.5)** | (10.5) |
| Net debt<sup>(1)</sup> | **4867.6** | 4417.1 |

---

(1) This is a non-GAAP financial measure or ratio. See section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

QUARTERLY REPORT - Q1 2026 P.26

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

The primary measure used by the Company to monitor its financial leverage is its net debt leverage ratio as defined in section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A. Gildan's net debt leverage ratio as at March 29, 2026 was 3.3 times (3.0 times at December 28, 2025). As a result of the closing of the Hanes acquisition, our net debt leverage ratio exceeded our stated target range. Accordingly, we paused our share repurchases starting in August 2025, and we expect share repurchases to resume when the net debt leverage ratio approximates the midpoint of the target range. The Company's net debt leverage ratio is calculated as follows:

---

| | | |
|:---|:---|:---|
| *(in $ millions, or otherwise indicated)* | **Mar 29, 2026** | Dec 28, 2025 |
| Adjusted EBITDA for the trailing twelve months (excluding discontinued operations) <sup>(1)</sup> | **981.3** | 926.3 |
| Adjustment for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Business acquisitions<sup>(3)</sup> | **472.0** | 564.8 |
| Pro-forma adjusted EBITDA for the trailing twelve months | **1453.3** | 1491.1 |
| Net debt<sup>(1)</sup> | **4867.6** | 4417.1 |
| Net debt leverage ratio<sup>(1)(2)</sup> | **3.3** | 3.0 |

---

(1) This is a non-GAAP financial measure or ratio. See section 15.0 "Definition and reconciliation of non-GAAP financial measures and related ratios" in this MD&A.

(2) The Company's net debt to EBITDA ratio for purposes of its term loans and revolving facility was 3.4x and for purposes of U.S. private placement notes was 3.8x at March 29, 2026 (3.1x and 3.4x respectively at December 28, 2025).

(3) Includes the adjusted EBITDA of Hanes for the period beginning March 31, 2025 and ending November 30, 2025 (including HAA), and the adjusted EBITDA of the HAA business (which was classified as discontinued operations as at the date of acquisition) for the period beginning December 1, 2025 and ending March 29, 2026. The adjusted EBITDA of Hanes and of HAA varies from the definition of the Company's adjusted EBITDA as presented in this MD&A in certain respects. The adjusted EBITDA of Hanes (including HAA) was calculated using EBITDA previously reported by Hanes (excluding adjustments made by HanesBrands to align the presentation in its public filings with the definition used in its then credit agreement), and is adjusted to comply with IFRS and Gildan's accounting policies, and includes on a proforma basis the impact of the purchase price allocation for the acquisition of HanesBrands, including fair value adjustments determined provisionally and the impact of reduced compensation and director fees from post-acquisition severance.

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

The total net debt to EBITDA ratios (as defined in the credit facility agreement and its amendments, and in the U.S. private placement note agreement) vary from the definition of the Company's non-GAAP ratio and non-GAAP financial measures "net debt leverage ratio" and "adjusted EBITDA" respectively, as presented in this MD&A in certain respects. The definitions in the loan and note agreements are based on accounting for all leases in accordance with previous accounting principles whereby the Company's leases for premises were accounted for as operating leases, while the Company's reported net debt leverage ratio reflects lease accounting in accordance with the Company's current accounting policies. In addition, adjustments permitted to EBITDA in the loan and note agreements vary from the adjustments used by the Company in calculating its adjusted EBITDA non-GAAP financial measure. As a result of these differences, our total net debt to EBITDA ratio for purposes of our term loans and revolving facility was 3.4x (3.1x at December 28, 2025), and for purposes of our U.S. private placement note agreements was 3.8x at March 29, 2026 (3.4x at December 28, 2025).

The Company, upon approval from its Board of Directors, may issue or repay long-term debt, issue or repurchase shares, or undertake other activities as deemed appropriate under specific circumstances.

QUARTERLY REPORT - Q1 2026 P.27

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**8.3 Off-balance sheet arrangements and maturity analysis of contractual obligations**

In the normal course of business, we enter into contractual obligations that will require us to disburse cash over future periods. The following table sets forth the maturity of our contractual obligations by period as at March 29, 2026.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| *(in $ millions)* | **Carrying amount** | Contractual cash flows | Less than 1 year | 1 to 3 years | 4 to 5 years | More than 5 years |
| Accounts payable and accrued liabilities | **1051.2** | 1051.2 | 1051.2 |  |  |  |
| Long-term debt<sup>(1)</sup> | **4715.1** | 4715.1 | 450.0 | 1352.5 | 2168.3 | 744.3 |
| Interest obligations<sup>(2)</sup> | **—** | 973.6 | 230.2 | 390.3 | 200.9 | 152.2 |
| Purchase and other obligations<sup>(3)</sup> | **—** | 722.3 | 397.1 | 190.8 | 89.1 | 45.3 |
| Lease obligations | **296.7** | 345.4 | 65.2 | 129.0 | 64.6 | 86.6 |
| Total contractual obligations | **6063.0** | 7807.6 | 2193.7 | 2062.6 | 2522.9 | 1028.4 |

---

(1) See Section 8.2 "Long-term debt and net debt and net debt leverage ratio" for additional details on the Company's long-term debt (including the current portion thereof).

(2) Interest obligations include expected interest payments on long-term debt as at March 29, 2026 (assuming balances remain outstanding through to maturity). For variable rate debt, the Company has applied the rate applicable at March 29, 2026 to the currently established maturity dates. These amounts include the effects of the hedging instruments.

(3) Purchase and other obligations includes commitments to purchase raw materials and equipment, as well as minimum royalty obligations and other contractual commitments.

As disclosed in note 26 to our fiscal 2025 audited annual consolidated financial statements, we have granted financial guarantees, irrevocable standby letters of credit, and surety bonds to third parties to indemnify them in the event the Company and some of our subsidiaries do not perform their contractual obligations. As at March 29, 2026, the maximum potential liability under these guarantees was $155 million, of which $75 million was for surety bonds and $80 million was for financial guarantees and standby letters of credit.

**8.4 Derivative instruments**

The Company may periodically use derivative financial instruments to manage risks related to fluctuations in foreign exchange rates, commodity prices, interest rates, and changes in the price of our common shares under our share-based compensation plans. Derivative financial instruments are not used for speculative purposes. As at March 29, 2026, the Company's outstanding derivative financial instruments (most of which are designated as effective hedging instruments) consist of foreign exchange and commodity forward, option, cross currency and interest rate swap contracts on senior notes, as well as floating-to-fixed interest rate swaps to fix the variable interest rates on a designated portion of borrowings under the Company's term loans and unsecured notes. For more information about our derivative financial instruments, please refer to notes 10 and 11 to the unaudited condensed interim consolidated financial statements as at and for the three months ended March 29, 2026.

**8.5 Outstanding share data**

Our common shares are listed on the New York Stock Exchange (NYSE) and the Toronto Stock Exchange (TSX) under the symbol GIL. As at April 27, 2026, there were 185,180,953 common shares issued and outstanding along with 27,999 stock options and 1,675,252 dilutive restricted share units (Treasury RSUs) outstanding. Each stock option entitles the holder to purchase one common share at the end of the vesting period at a predetermined option exercise price. Each Treasury RSU entitles the holder to receive one common share from treasury at the end of the vesting period, subject to the attainment of performance conditions, without any monetary consideration being paid to the Company. Treasury RSUs are primarily used as part of special long-term plans, to attract candidates or for retention purposes, and their vesting conditions, including any performance objectives, and are determined by the Board of Directors at the time of grant.

QUARTERLY REPORT - Q1 2026 P.28

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**8.6 Declaration of dividend**

On April 29, 2026, the Board of Directors declared a cash dividend of $0.249 per share for an expected aggregate payment of $46 million which will be paid on June 15, 2026 on all of the issued and outstanding common shares of the Company, rateably and proportionately, to the holders of record on May 20, 2026. This dividend is an "eligible dividend" for the purposes of the Income Tax Act (Canada) and any other applicable provincial legislation pertaining to eligible dividends.

As part of the Company's capital allocation framework as described in section 8.1 of this MD&A, the Board of Directors considers several factors when deciding to declare quarterly cash dividends, including the Company's present and future earnings, cash flows for working capital requirements, capital expenditures, debt covenant and repayment obligations, capital requirements, the macro-economic environment, and present and/or future regulatory and legal restrictions.

The Company's dividend payout policy and the declaration of dividends are subject to the discretion of the Board of Directors and, consequently, there can be no assurances that Gildan's dividend policy will be maintained or that dividends will be declared in respect of any quarter or other future periods. The declaration of dividends by the Board of Directors is ultimately dependent on the Company's operations and financial results which are, in turn, subject to various assumptions and risks, including those set out in this MD&A.

**8.7 Normal course issuer bid (NCIB)**

As discussed in section 8.1 "Capital allocation framework" of this MD&A, we have paused our share repurchases until our net debt leverage ratio approximates the midpoint of the target range. As such the NCIB program, which expired on August 8, 2025, has not been renewed.

**9.0 LEGAL PROCEEDINGS**

**9.1 Claims and litigation**

The Company is a party to claims and litigation arising in the normal course of operations. The Company does not expect the resolution of these matters to have a material adverse effect on the financial position or results of operations of the Company.

We record a liability when we believe that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. Significant judgment is required to determine both the probability of having incurred a liability and the estimated amount of the liability. We review these matters at least quarterly and adjust these liabilities to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other updated information and events, pertaining to a particular case.

**10.0 FINANCIAL RISK MANAGEMENT**

The Company is exposed to risks arising from financial instruments, including credit risk, liquidity risk, foreign currency risk, interest rate risk, commodity price risk, as well as risks arising from changes in the price of our common shares under our share-based compensation plans. Please refer to note 28 of the audited annual consolidated financial statements for the year ended December 28, 2025 for additional details, and for more information about our derivative financial instruments, please refer to notes 10 and 11 of the unaudited condensed interim consolidated financial statements as at and for the three months ended March 29, 2026.

QUARTERLY REPORT - Q1 2026 P.29

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**11.0 CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS**

Our material accounting policies are described in note 3 to our fiscal 2025 audited annual consolidated financial statements. The preparation of financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income, and expenses. Actual results may differ from these estimates.

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.

**11.1 Critical judgments in applying accounting policies**

The following are critical judgments that management has made in the process of applying accounting policies and that have the most significant effect on the amounts recognized in the consolidated financial statements:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Business acquisitions

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Determination of cash-generating units (CGUs)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Inventories

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Income taxes

**12.0 ACCOUNTING POLICIES AND NEW ACCOUNTING STANDARDS NOT YET APPLIED**

**12.1 Accounting policies**

The Company's unaudited condensed interim consolidated financial statements as at and for the three months ended March 29, 2026 were prepared in accordance with International Accounting Standard ("IAS") 34, Interim Financial Reporting, as issued by the International Accounting Standards Board ("IASB"). The Company applied the same accounting policies in the preparation of the unaudited condensed interim consolidated financial statements as at and for the three months ended March 29, 2026 as those disclosed in note 3 of its fiscal 2025 audited annual consolidated financial statements, except for the adoption of new or amended accounting standards effective as of December 29, 2025 as described below.

<u>On December 29, 2025, the Company adopted the following new or amended accounting standards:</u> 

*IFRS 9 Financial Instruments ("IFRS 9") and IFRS 7 Financial Instruments: Disclosures ("IFRS 7")*<br>In May 2024, IASB issued limited amendments to IFRS 9 and IFRS 7. These amendments provide clarity on the timing of recognition and derecognition of financial assets and liabilities, the assessment of contractual cash flow characteristics, and the resulting classification and disclosure of financial assets with environmental, social, and governance-linked or other contingent features. Additionally, the amendments clarify that a financial liability is derecognized on the settlement date, with the accounting policy choice to derecognize a financial liability settled using an electronic payment system before the settlement date, provided specific conditions are met. Additional disclosures are required for financial instruments with contingent features and investments in equity instruments designated at fair value through other comprehensive income with these amendments. These amendments are effective for annual reporting periods beginning on or after January 1, 2026. The adoption of these standards, at the beginning of this interim period, was applied prospectively, in accordance with the respective transition provisions. The prospective application means that the new requirements are applied only to transactions, events, or balances occurring after the date of initial application, with no restatement of prior periods. The adoption of these standards did not have an impact on the Company's condensed interim consolidated financial statements for the period ended March 29, 2026. As a result, there were no adjustments to the opening balances of assets, liabilities, or equity as at the date of initial application.

QUARTERLY REPORT - Q1 2026 P.30

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**12.2 New accounting standards and interpretations not yet applied**

<br> **IFRS 18 Presentation and Disclosure in Financial Statements**

On April 9, 2024, the IASB issued IFRS 18 to improve reporting of financial performance. IFRS 18 replaces IAS 1 Presentation of Financial Statements. It carries forward many requirements from IAS 1 unchanged. The standard sets out requirements on presentation and disclosures in financial statements. It introduces a defined structure for the statement of income composed of required categories and subtotals. The standard also introduces specific disclosure requirements for management-defined performance measures and a reconciliation between these measures and the most similar subtotal specified in IFRS, which must be disclosed in a single note. IFRS 18 applies for annual reporting periods beginning on or after January 1, 2027. Earlier application is permitted. The Company is currently evaluating the impact of the adoption of IFRS 18 on its consolidated financial statements.

**13.0 INTERNAL CONTROL OVER FINANCIAL REPORTING**

**Changes in internal controls and procedures**

There have been no changes in the Company's internal control over financial reporting that occurred during the period beginning on December 28, 2025 and ended on March 29, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. As disclosed in our 2025 Annual MD&A, we have limited the scope of our evaluation of internal controls over financial reporting (ICFR) to exclude controls over financial reporting of Hanes, a subsidiary acquired by the Company in connection with an acquisition consummated on December 1, 2025. In addition, we have also limited the scope of our evaluation of disclosure controls and procedures (DC&P) to exclude disclosure controls and procedures of Hanes. The net sales originating from the financial records of Hanes which were included in the condensed interim consolidated results of the Company for the three month period ended March 29, 2026 represented approximately 45% of total net sales. Hanes accounted for approximately $2,313 million of current assets, $3,809 million of non-current assets, $986 million of current liabilities, and $1,703 million of non-current liabilities, in the Company's condensed interim consolidated statement of financial position as at March 29, 2026.

**14.0 RISKS AND UNCERTAINTIES**

In note 28 of our 2025 audited annual consolidated financial statements we describe certain risks related to financial instruments and in our 2025 Annual MD&A under the section "Risks and uncertainties", we describe the principal risks that could have a material and adverse effect on our financial condition, results of operations or business, cash flows, or the trading price of our common shares, as well as cause actual results to differ materially from our expectations expressed in or implied by our forward-looking statements. The risks listed below are not the only risks that could affect the Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially and adversely affect our financial condition, results of operations, cash flows, or business. The risks described in our 2025 Annual MD&A include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to implement our growth strategies and plans

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to compete effectively

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to integrate acquisitions

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may be negatively impacted by changes in general economic and financial conditions

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We rely on a small number of significant customers

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our customers do not commit to purchase minimum quantities

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to anticipate, identify, or react to changes in consumer preferences and trends

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to manage production and inventory levels effectively in relation to changes in customer demand

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may be negatively impacted by fluctuations and volatility in the price of raw materials used to manufacture our products

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We rely on key suppliers

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The success of our marketing, promotional, and innovation programs

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company's level of indebtedness could have a variety of consequences on the Company's business and operations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may be negatively impacted by climate, political, social, and economic risks, natural disasters, pandemics, and endemics in the countries in which we operate or from which we source production

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Compliance with laws and regulations in the various countries in which we operate and the potential negative effects of litigation and/or regulatory actions

QUARTERLY REPORT - Q1 2026 P.31

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We rely on certain international trade (including multilateral and bilateral) agreements and preference programs and are subject to evolving international trade regulations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Factors or circumstances that could increase our effective income tax rate

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Compliance with environmental and health and safety regulations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Global climate change could have an adverse impact on our business

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Compliance with product safety regulations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may be negatively impacted by changes in our relationship with our employees or changes to domestic and foreign employment regulations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may experience negative publicity as a result of actual, alleged, or perceived violations of labour laws or international labour standards, unethical labour, and other business practices

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to protect our intellectual property rights

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to protect the strength and reputation of our brands

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We rely significantly on our information systems for our business operations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may be negatively impacted by data security breaches or data privacy violations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Rapid developments in artificial intelligence (AI) could adversely impact our business

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on key management and our ability to attract and/or retain key personnel

In late February 2026, the United States and Israel launched military operations against Iran, resulting in an armed conflict that has caused significant disruption to the Middle East region as well as the global energy markets and international shipping, including the closure of the Strait of Hormuz. Such disruptions have caused increased global uncertainty, significant disruptions in global energy markets and inflationary conditions arising from elevated energy costs. The ongoing energy markets situation may cause important disruptions to our operations, including in Bangladesh, given their reliance on imported fuels, particularly diesel and natural gas. Disruptions in the global energy markets could cause shortages of diesel and natural gas, outages or shutdowns at certain of our facilities or those of our suppliers and customers, extended lead times for delivery of raw materials, as well as, in certain cases, additional costs and production slowdowns, which, in turn, could have a material adverse effect on our financial condition, results of operations, business or cash flows.

See section 3.4 "Recent Events" for a discussion on the tariffs imposed by the U.S. administration and related risks and uncertainties.

**15.0 DEFINITION AND RECONCILIATION OF NON-GAAP FINANCIAL MEASURES AND RELATED RATIOS**

We use non-GAAP financial measures, as well as non-GAAP ratios to assess our operating and financial performance, financial condition and leverage, and liquidity. The terms and definitions of the non-GAAP financial measures used in this MD&A and a reconciliation of each non-GAAP measure to the most directly comparable GAAP measure are provided below. The non-GAAP financial measures are presented on a consistent basis for all periods presented in this MD&A. These measures do not have any standardized meanings prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Accordingly, they should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS.

**Non-GAAP financial measures and related ratios**

In this MD&A we use the following non-GAAP financial measures (on a continuing operations basis): adjusted net earnings, adjusted earnings before income taxes, adjusted income tax expense, adjusted gross profit, adjusted SG&A expenses, adjusted operating income, adjusted EBITDA. We also use the following non-GAAP ratios (on a continuing operations basis): adjusted diluted EPS, adjusted effective income tax rate, adjusted gross margin, adjusted SG&A expenses as a percentage of net sales, and adjusted operating margin. These financial metrics are used to measure our performance and financial condition from one period to the next, which excludes the variation caused by certain adjustments that could potentially distort the analysis of trends in our operating and financial performance, and because we believe such measures provide meaningful information on the Company's operating and financial performance and financial condition. Excluding these items does not imply they are non-recurring. Free cash flow is a non-GAAP financial measure that is presented including both continuing and discontinued operations, as this best represents the measure of the Company's ability to pay off incurred debt to manage its capital structure. We also use non-GAAP financial measures which include both total debt and net debt (including assets and liabilities held for sale), net debt leverage ratio (including assets and liabilities held for sale and both continuing and discontinued operations), as well as working capital excluding assets and liabilities held for sale.

QUARTERLY REPORT - Q1 2026 P.32

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**Certain adjustments to non-GAAP measures**

As noted above certain of our non-GAAP financial measures and ratios exclude the variation caused by certain adjustments that affect the comparability of the Company's operating and financial results and could potentially distort the analysis of trends in its business performance. The non-GAAP financial measures referred to in this MD&A are presented for continuing operations (unless otherwise noted) and therefore exclude the results from discontinued operations. Discontinued operations include the results from the HAA operations, which have been classified as held for sale and reported as discontinued operations as of December 1, 2025, the date of closing of the Hanes acquisition. The classification of HAA as held for sale has no impact on the comparative periods and financial measures previously reported by the Company since the acquisition of HanesBrands was completed in the fourth quarter of 2025 and results from the HanesBrands operations (including HAA) were therefore not included in the Company's results in respect of prior financial years or interim periods. Adjustments which impact more than one non-GAAP financial measure and ratio are explained below:

*Restructuring and acquisition-related costs*

Restructuring and acquisition-related costs are comprised of costs directly related to significant exit activities, including the closure of business locations and sale of business locations or the relocation of business activities, significant changes in management structure, as well as transaction, exit, and integration costs incurred pursuant to business acquisitions. Restructuring and acquisition-related costs are included as an adjustment in arriving at adjusted operating income, adjusted operating margin, adjusted net earnings, adjusted earnings before income taxes, adjusted diluted EPS, and adjusted EBITDA. For the three months ended March 29, 2026, restructuring and acquisition-related costs of $61 million, (2025 - $5 million) were recognized. Subsection 5.4.4 entitled "Restructuring and acquisition-related costs" in this MD&A contains a detailed discussion of these costs.

*Inventory fair value step-up cost recorded as part of the Hanes business acquisition*

In accordance with IFRS 3 Business Combinations, acquired inventory must be recognized and measured at its acquisition-date fair value. This fair value measurement for work in progress and finished goods inventory (based on estimated selling prices in the ordinary course of business, minus the sum of the costs completion of production of the inventory, selling and a reasonable profit margin for the completion and selling effort) resulted in an increase to Hanes' historical carrying amount of inventory recognized in the purchase price allocation. Such amount, is subsequently recognized as an increase to cost of goods sold in the months following the acquisition as goods resulting from such inventory are sold ($106.3 million for the three months ends March 29, 2026). The residual step up cost, of $95 million, is expected to turn over within approximately five months. As a result, this adjustment is not expected to recur beyond one year. The impact of this step-up cost was included as an adjustment in arriving at adjusted gross profit, adjusted gross margin, adjusted operating income, adjusted operating margin, adjusted earnings before income taxes, adjusted income tax expense, adjusted net earnings, adjusted diluted EPS, and adjusted EBITDA.<br>

QUARTERLY REPORT - Q1 2026 P.33

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

*Costs relating to proxy contest and leadership changes and related matters*

On December 11, 2023, the Company's then Board of Directors (the "Previous Board") announced the termination of the Company's President and Chief Executive Officer, Glenn Chamandy. On such date, the Previous Board appointed Vince Tyra as President and Chief Executive Officer, and Mr. Tyra took office in the first quarter of fiscal 2024, effective on January 15, 2024. Following the termination of Mr. Chamandy, shareholder Browning West and others initiated a campaign and proxy contest against the Previous Board, proposing a new slate of Directors and requesting the reinstatement of Mr. Chamandy as President and Chief Executive Officer. In the second quarter of 2024, on April 28, 2024, in advance of the May 28, 2024, Annual General Meeting of Shareholders ("Annual Meeting"), the Previous Board announced a refreshed Board of Directors ("Refreshed Board") that resulted in the immediate replacement of five Directors, with two additional Directors staying on temporarily but not standing for re-election at the Annual Meeting. On May 23, 2024, five days prior to the Annual Meeting, the Refreshed Board and Mr. Tyra resigned, along with Arun Bajaj, the Company's Executive Vice-President, Chief Human Resources Officer (CHRO) and Legal Affairs. The Refreshed Board appointed Browning West's nominees to the Board of Directors (the "New Board"), effective as of that date. On May 24, 2024, the New Board reinstated Mr. Chamandy as President and Chief Executive Officer. On May 28, 2024, the New Board was elected by shareholders at the Annual Meeting. The Company incurred significant expenses primarily at the direction of the Previous Board and the Refreshed Board, including: (i) legal, communication, proxy advisory, financial and other advisory fees relating to the proxy contest and related matters and the termination and subsequent reinstatement of Mr. Chamandy; (ii) legal, financial and other advisory fees with respect to a review process initiated by the Previous Board following receipt of a confidential non-binding expression of interest to acquire the Company; (iii) special senior management retention awards; (iv) severance and termination benefits relating to outgoing executives; and (v) incremental director meeting fees and insurance premiums. In addition, subsequent to the Annual Meeting, the Corporate Governance and Social Responsibility Committee (the "CGSRC") recommended to the New Board, and the New Board approved, back-pay compensation for Mr. Chamandy (who did not receive any severance payment following his termination on December 11, 2023), relating to his reinstatement, including the reinstatement of share-based awards that were canceled by the Previous Board.

The total costs relating to these non-recurring events ("Costs relating to proxy contest and leadership changes and related matters") amounted to $0.8 million for the three months ended March 29, 2026 (2025 - $0.9 million), as itemized in the table below with corresponding footnotes. Such costs are included in selling, general and administrative expenses. The impact of the below charges is included as adjustments in arriving at adjusted SG&A expenses, adjusted SG&A expenses as a percentage of net sales, adjusted operating income, adjusted operating margin, adjusted earnings before income taxes, adjusted net earnings, adjusted diluted EPS, and adjusted EBITDA.

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| *(in $ millions)* | **Mar 29,<br>2026** | Mar 30,<br>2025 |
| Advisory fees on shareholder matters<sup>(1)</sup> | **0.8** | 0.6 |
| Incremental costs relating to the Previous Board and Refreshed Board<sup>(2)</sup> | **—** | 0.1 |
| Special retention awards, net of jobs credit<sup>(3)</sup> | **—** | 0.2 |
| Costs relating to proxy contest and leadership changes and related matters | **0.8** | 0.9 |

---

(1) Relates to advisory, legal and other expenses for the proxy contest and shareholder matters.

(2) The Company incurred nil (2025 - $0.1 million) of incremental costs relating to the Previous Board and Refreshed Board. The charge related to the increase in the value of unpaid deferred share units (DSUs).

(3) Stock-based compensation expenses of nil for the three months ended March 29, 2026 (2025 - $0.2 million), relating to special retention awards, net of jobs credit.

QUARTERLY REPORT - Q1 2026 P.34

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**Adjusted net earnings and adjusted diluted EPS from continuing operations**

Adjusted net earnings from continuing operations are calculated as net earnings from continuing operations before restructuring and acquisition-related costs, impairment (impairment reversal) of intangible assets, net insurance gains, gain on sale and leaseback, costs relating to proxy contest and leadership related matters, bridge facility commitment fees, inventory fair value step-up cost recorded as part of the Hanes business acquisition, net interest incurred on bond issuance previous to Hanes transaction close, gain on debt redemption, net of debt breakage fee and income tax expense or recovery relating to these items. Adjusted net earnings from continuing operations also excludes income taxes related to the re-assessment of the probability of realization of previously recognized or de-recognized deferred income tax assets, income taxes relating to the revaluation of deferred income tax assets and liabilities as a result of statutory income tax rate changes in the countries in which we operate, and income tax recoveries relating to foreign income tax credits on acquisition-related actions. Adjusted diluted EPS from continuing operations is calculated as adjusted net earnings from continuing operations divided by the diluted weighted average number of common shares outstanding for the period. The Company uses adjusted net earnings from continuing operations and adjusted diluted EPS from continuing operations to measure its net earnings from continuing operations performance from one period to the next, and in making decisions regarding the ongoing operations of its business, without the variation caused by the impacts of the items described above. The Company excludes these items because they affect the comparability of its net earnings and diluted EPS and could potentially distort the analysis of net earnings trends in its business performance. The Company believes adjusted net earnings from continuing operations and adjusted diluted EPS from continuing operations are useful to investors because they help identify underlying trends in our business that could otherwise be masked by certain expenses, write-offs, charges, income or recoveries that can vary from period to period. Excluding these items does not imply they are non-recurring. These measures do not have any standardized meanings prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies.

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| *(in $ millions, except per share amounts)* | **Mar 29,<br>2026** | Mar 30,<br>2025 |
| Net earnings (loss) from continuing operations | **(55.1)** | 84.7 |
| Adjustments for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and acquisition-related costs | **61.0** | 5.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventory fair value step-up cost recorded as part of the Hanes business acquisition | **106.3** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Costs relating to proxy contest and leadership changes and related matters | **0.8** | 0.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax recovery relating to the above-noted adjustments | **(33.0)** | (0.7) |
| Adjusted net earnings from continuing operations | **80.0** | 89.9 |
| Basic EPS (loss) from continuing operations | **(0.30)** | 0.56 |
| Diluted EPS (loss) from continuing operations | **(0.30)** | 0.56 |
| Adjusted diluted EPS from continuing operations<sup>(1)</sup> | **0.43** | 0.59 |

---

(1) This is a non-GAAP ratio. It is calculated as adjusted net earnings from continuing operations divided by the diluted weighted average number of common shares outstanding.

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

QUARTERLY REPORT - Q1 2026 P.35

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**Adjusted earnings before income taxes, adjusted income tax expense, and adjusted effective income tax rate**

Adjusted effective income tax rate is defined as adjusted income tax expense divided by adjusted earnings from continuing operations before income taxes. Adjusted earnings before income taxes excludes discontinued operations, restructuring and acquisition-related costs, impairment (impairment reversal) of intangible assets, net insurance gains, gain on sale and leaseback, costs relating to proxy contest and leadership changes and related matters, bridge facility commitment fees, inventory fair value step-up cost recorded as part of the Hanes business acquisition, net interest incurred on bond issuance previous to Hanes transaction close, and gain on debt redemption, net of breakage fee. Adjusted income tax expense (which excludes discontinued operations) is defined as income tax expense excluding tax rate changes resulting in the revaluation of deferred income tax assets and liabilities, income taxes relating to the re-assessment of the probability of realization of previously recognized or de-recognized deferred income tax assets, income tax expense relating to restructuring charges and other pretax adjustments noted above, and income tax recoveries relating to foreign income tax credits on acquisition-related actions. The Company excludes these adjustments because they affect the comparability of its effective income tax rate. The Company believes the adjusted effective income tax rate provides a clearer understanding of our normalized effective tax rate and financial performance for the current period and for purposes of developing its annual financial budgets. The Company believes that adjusted effective income tax rate is useful to investors in assessing the Company's future effective income tax rate as it identifies certain pre-tax expenses and gains and income tax charges and recoveries which are not expected to recur on a regular basis (in particular, non-recurring costs such as proxy contest and leadership changes and related matters incurred in the Company's Canadian legal entity which do not result in tax recoveries, and tax rate changes resulting in the revaluation of deferred income tax assets and liabilities).

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| *(in $ millions, or otherwise indicated)* | **Mar 29,<br>2026** | Mar 30,<br>2025 |
| Earnings (loss) from continuing operations before income taxes | **(68.0)** | 99.8 |
| Adjustments for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and acquisition-related costs | **61.0** | 5.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventory fair value step-up cost recorded as part of the Hanes business acquisition | **106.3** |  |
| &nbsp;&nbsp;&nbsp;Costs relating to proxy contest and leadership changes and related matters | **0.8** | 0.9 |
| Adjusted earnings before income taxes | **100.1** | 105.7 |
| Income tax expense (recovery) | **(13.0)** | 15.1 |
| Adjustments for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax recovery relating to restructuring charges and other adjustments above | **33.0** | 0.7 |
| Adjusted income tax expense | **20.0** | 15.8 |
| Average effective income tax rate<sup>(1)</sup> | **19.1%** | 15.1% |
| Adjusted effective income tax rate<sup>(2)</sup> | **20.0%** | 15.0% |

---

(1) Average effective income tax rate is calculated as income tax expense divided by earnings before income taxes.

(2) This is a non-GAAP ratio. It is calculated as adjusted income tax expense divided by adjusted earnings before income taxes.

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

QUARTERLY REPORT - Q1 2026 P.36

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**Adjusted gross profit and adjusted gross margin**

Adjusted gross profit (which excludes discontinued operations) is calculated as gross profit excluding the impact of a new adjustment incurred as a result of the inventory fair value step-up recorded in the Hanes business acquisition. Adjusted gross profit also excludes the impact of net insurance gains and the impact of the Company's strategic product line initiatives, as applicable. In accordance with IFRS 3 Business Combinations, acquired inventory must be recognized and measured at its acquisition-date fair value. This fair value measurement for work in progress and finished goods inventory (based on estimated selling prices in the ordinary course of business, minus the sum of the costs of completion production of the inventory, selling and a reasonable profit margin for the completion and selling effort) resulted in an increase to Hanes' historical carrying amount of inventory recognized in the purchase price allocation. Such amount, is subsequently recognized as an increase to cost of goods sold in the months following the acquisition as goods resulting from such inventory are sold. The inventory is expected to turn over within approximately eight months. As a result, this adjustment is not expected to recur beyond one year. The adjusted gross margin therefore reflects the cost of sales impact of historical cost of Hanes inventory in its books that has been sold in the current period. The Company believes this adjustment enhances comparability by removing the one-time impact of purchase accounting on gross margin, providing investors with a view of performance on a consistent basis with prior periods as the inventory step-up is not indicative of ongoing operations. Adjusted gross margin is calculated as adjusted gross profit divided by net sales. The Company uses adjusted gross profit and adjusted gross margin to measure its performance from one period to the next, without the variation caused by the impacts of the inventory fair value step-up recorded in connection with the Hanes business acquisition described above. The Company excludes such item because it affects the comparability of its financial results and could potentially distort the analysis of trends in its business performance. The Company also believes adjusted gross profit and adjusted gross margin are useful to management and investors because they help identify underlying trends in our business in how efficiently the Company uses labor and materials for manufacturing goods to our customers that could otherwise be masked by the impact of net insurance gains in prior years. These measures do not have any standardized meanings prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies.

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| *(in $ millions, or otherwise indicated)* | **Mar 29,<br>2026** | Mar 30,<br>2025 |
| Gross profit | **278.4** | 221.9 |
| Adjustment for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventory fair value step-up cost recorded as part of the Hanes business acquisition | **106.3** |  |
| Adjusted gross profit | **384.7** | 221.9 |
| Net sales | **1165.9** | 711.7 |
| Gross margin | **23.9%** | 31.2% |
| Adjusted gross margin<sup>(1)</sup> | **33.0%** | 31.2% |

---

(1) This is a non-GAAP ratio. It is calculated as adjusted gross profit divided by net sales.

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

**Adjusted SG&A expenses and adjusted SG&A expenses as a percentage of net sales**

Adjusted SG&A expenses (which excludes discontinued operations) are calculated as selling, general and administrative expenses excluding the impact of costs relating to proxy contest and leadership changes and related matters. The Company uses adjusted SG&A expenses and adjusted SG&A expenses as a percentage of net sales (which excludes discontinued operations) to measure its performance from one period to the next, without the variation caused by the impact of the items described above. Excluding these items does not imply they are non-recurring. The Company believes adjusted SG&A expenses and adjusted SG&A expenses as a percentage of net sales are useful to investors because they help identify underlying trends in our business that could otherwise be masked by costs relating to the proxy contest and leadership changes and related matters, which the Company believes are unusual and non-recurring in nature. These measures do not have any standardized meanings prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies.

QUARTERLY REPORT - Q1 2026 P.37

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| *(in $ millions, or otherwise indicated)* | **Mar 29,<br>2026** | Mar 30,<br>2025 |
| SG&A expenses | **218.7** | 87.3 |
| Adjustment for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Costs relating to proxy contest and leadership changes and related matters | **(0.8)** | (0.9) |
| Adjusted SG&A expenses | **217.9** | 86.4 |
| SG&A expenses as a percentage of net sales | **18.8%** | 12.3% |
| Adjusted SG&A expenses as a percentage of net sales<sup>(1)</sup> | **18.7%** | 12.1% |

---

(1) This is a non-GAAP ratio. It is calculated as adjusted SG&A expenses divided by net sales.

**Adjusted operating income and adjusted operating margin**

Adjusted operating income (which excludes discontinued operations) is calculated as operating income before restructuring and acquisition-related costs, and excludes impairment (impairment reversal) of intangible assets, net insurance gains, gain on sale and leaseback, costs relating to proxy contest and leadership changes and related matters and inventory fair value step-up cost recorded as part of the Hanes business acquisition. Management uses adjusted operating income and adjusted operating margin to measure its performance at the operating income level as we believe it provides a better indication of our operating performance and facilitates the comparison across reporting periods, without the variation caused by the impacts of the items described above. The Company excludes these items because they affect the comparability of its operating results and could potentially distort the analysis of trends in its operating income and operating margin performance. The Company believes adjusted operating income and adjusted operating margin are useful to investors because they help identify underlying trends in our business in how efficiently the Company generates profit from its primary operations that could otherwise be masked by the impact of the items noted above that can vary from period to period. Excluding these items does not imply they are non-recurring. These measures do not have any standardized meanings prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies.

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| *(in $ millions, or otherwise indicated)* | **Mar 29,<br>2026** | Mar 30,<br>2025 |
| Operating income (loss) | **(1.3)** | 129.6 |
| Adjustments for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and acquisition-related costs | **61.0** | 5.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventory fair value step-up cost recorded as part of the Hanes business acquisition | **106.3** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Costs relating to proxy contest and leadership changes and related matters | **0.8** | 0.9 |
| Adjusted operating income | **166.8** | 135.5 |
| Operating margin | **(0.1)%** | 18.2% |
| Adjusted operating margin<sup>(1)</sup> | **14.3%** | 19.0% |

---

(1) This is a non-GAAP ratio. It is calculated as adjusted operating income divided by net sales.

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

QUARTERLY REPORT - Q1 2026 P.38

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**Adjusted EBITDA**

Adjusted EBITDA (which excludes discontinued operations) is calculated as net earnings from continuing operations before financial expenses net, income taxes, and depreciation and amortization, and excludes the impact of restructuring and acquisition-related costs. Adjusted EBITDA also excludes impairment (impairment reversal) of intangible assets, net insurance gains, gain on sale and leaseback, costs relating to proxy contest and leadership changes and related matters and inventory fair value step-up cost recorded as part of the Hanes business acquisition. Management uses adjusted EBITDA, among other measures, to facilitate a comparison of the profitability of its business on a consistent basis from period-to-period and to provide a more complete understanding of factors and trends affecting our business. The Company also believes this measure is commonly used by investors and analysts to assess profitability and the cost structure of companies within the industry, as well as measure a company's ability to service debt and to meet other payment obligations, or as a common valuation measurement. The Company excludes depreciation and amortization expenses, which are non-cash in nature and can vary significantly depending upon accounting methods or non-operating factors. Excluding these items does not imply they are non-recurring. This measure does not have any standardized meanings prescribed by IFRS and is therefore unlikely to be comparable to similar measures presented by other companies.

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| *(in $ millions)* | **Mar 29,<br>2026** | Mar 30,<br>2025 |
| Net earnings (loss) from continuing operations | **(55.1)** | 84.7 |
| Restructuring and acquisition-related costs | **61.0** | 5.0 |
| Inventory fair value step-up cost recorded as part of the Hanes business acquisition | **106.3** |  |
| Costs relating to proxy contest and leadership changes and related matters | **0.8** | 0.9 |
| Depreciation and amortization | **54.2** | 30.3 |
| Financial expenses, net | **66.7** | 29.9 |
| Income tax expense | **(13.0)** | 15.1 |
| Adjusted EBITDA | **220.9** | 165.9 |

---

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

QUARTERLY REPORT - Q1 2026 P.39

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**Free cash flow**

Free cash flow is defined as cash flow from operating activities, less cash flow used in investing activities for continuing and discontinued operations, excluding cash flows relating to business acquisitions. The Company considers free cash flow to be an important indicator of the financial strength and liquidity of its business, and it is a key metric used by management in managing capital as it indicates how much cash is available after capital expenditures to repay debt, to pursue business acquisitions, and/or to redistribute to its shareholders. Management believes that free cash flow also provides investors with an important perspective on the cash available to us to service debt, fund acquisitions, and pay dividends. In addition, free cash flow is commonly used by investors and analysts when valuing a business and its underlying assets. This measure does not have any standardized meanings prescribed by IFRS and is therefore unlikely to be comparable to similar measures presented by other companies. In the event of a sale of HAA, the net proceeds from such disposition will be required to be used to repay the New Term Loan Facility in accordance with its terms.

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| *(in $ millions)* | **Mar 29,<br>2026** | Mar 30,<br>2025 |
| Cash flows from (used in) operating activities | **(279.5)** | (142.2) |
| Cash flows from (used in) investing activities | **(30.4)** | (23.3) |
| Adjustment for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash flows from business acquisitions | **—** |  |
| Free cash flow<sup>(1)</sup> | **(309.9)** | (165.5) |

---

(1) The cash flows related to discontinued operations have not been segregated. Accordingly, the cash flows provided include the results of continuing and discontinued operations

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

**Total debt and net debt**

Total debt is defined as the total bank indebtedness, long-term debt (including any current portion), foreign currency component of derivative financial instruments related to the cross-currency swap's notional amount, and lease obligations (including any current portion and including lease obligations included in liabilities held for sale), and net debt is calculated as total debt net of cash and cash equivalents (including cash and cash equivalents included in assets held for sale). The Company considers total debt and net debt to be important indicators for management and investors to assess the financial position and liquidity of the Company and measure its financial leverage. These measures do not have any standardized meanings prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies.

---

| | | |
|:---|:---|:---|
| *(in $ millions)* | **Mar 29, 2026** | Dec 28, 2025 |
| Long-term debt (including current portion) | **4715.1** | 4313.7 |
| Bank indebtedness | **—** |  |
| Foreign currency component of derivative financial instrument on Canadian Senior unsecured notes | **(23.8)** | (37.4) |
| Lease obligations (including current portion) | **296.7** | 314.5 |
| Lease obligations (including current portion) included in liabilities held for sale | **131.2** | 121.3 |
| Total debt | **5119.2** | 4712.1 |
| Cash and cash equivalents | **(237.1)** | (284.5) |
| Cash and cash equivalents included in assets held for sale | **(14.5)** | (10.5) |
| Net debt | **4867.6** | 4417.1 |

---

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

QUARTERLY REPORT - Q1 2026 P.40

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**Net debt leverage ratio**

The net debt leverage ratio is defined as the ratio of net debt to proforma adjusted EBITDA for the trailing twelve months, all of which are non-GAAP measures. The proforma adjusted EBITDA for the trailing twelve months reflects business acquisitions made during the period, as if they had occurred at the beginning of the trailing twelve month period, including from continuing and discontinued operations. The Company has currently set a net debt leverage target ratio of 1.5 to 2.5 times proforma adjusted EBITDA for the trailing twelve months. Upon the closing of the HanesBrands acquisition, the Company's net debt leverage ratio exceeded the stated target range, and accordingly the Company has paused its share repurchases and expects share repurchases to resume when its net debt leverage ratio approximates the midpoint of the target range. The net debt leverage ratio serves to evaluate the Company's financial leverage and is used by management in its decisions on the Company's capital structure, including financing strategy (including debt repayments), and business acquisitions and divestitures. The Company believes that certain investors and analysts use the net debt leverage ratio to measure the financial leverage of the Company, including its ability to pay off incurred debt. The Company's net debt leverage ratio differs from the net debt to EBITDA ratio that is a covenant in our loan and note agreements, and therefore the Company believes it is a useful additional measure. This measure does not have any standardized meanings prescribed by IFRS and is therefore unlikely to be comparable to similar measures presented by other companies.

---

| | | |
|:---|:---|:---|
| *(in $ millions, or otherwise indicated)* | **Mar 29, 2026** | Dec 28, 2025 |
| Adjusted EBITDA for the trailing twelve months (excluding discontinued operations) | **981.3** | 926.3 |
| Adjustment for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Business acquisitions<sup>(2)</sup> | **472.0** | 564.8 |
| Proforma adjusted EBITDA for the trailing twelve months | **1453.3** | 1491.1 |
| Net debt | **4867.6** | 4417.1 |
| Net debt leverage ratio<sup>(1)</sup> | **3.3** | 3.0 |

---

(1) The Company's total net debt to EBITDA ratio for purposes of its term loans and revolving facility was 3.4x (3.1x at December 28, 2025), and for purposes of U.S. private placement notes was 3.8x at March 29, 2026 (3.4x at December 28, 2025).

Refer to section 8.2 of this MD&A.

(2) Includes the adjusted EBITDA of Hanes for the period beginning March 30, 2025 and ending November 30, 2025 (including HAA), and the adjusted EBITDA of the HAA business (which was classified as discontinued operations as at the date of acquisition) for the period beginning on December 1, 2025 and ending on March 29, 2026). The adjusted EBITDA of Hanes and of HAA varies from the definition of the Company's adjusted EBITDA as presented in this MD&A in certain respects. The adjusted EBITDA of Hanes (including HAA) was calculated using EBITDA previously reported by Hanes (excluding adjustments made by HanesBrands to align the presentation in its public filings with the definition used in its then credit agreement), and is adjusted to comply with IFRS and Gildan's accounting policies, and includes on a proforma basis the impact of the purchase price allocation for the acquisition of HanesBrands, including fair value adjustments determined provisionally and the impact of reduced compensation and director fees from post-acquisition severance.

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

QUARTERLY REPORT - Q1 2026 P.41

------

---

| | |
|:---|:---|
| ![newheaderlogoeng.jpg](newheaderlogoeng.jpg) | MANAGEMENT'S DISCUSSION AND ANALYSIS |

---

**Working capital**

Working capital is a non-GAAP financial measure and is defined as current assets less current liabilities, excluding assets and liabilities held for sale. Management believes that working capital, in addition to other conventional financial measures prepared in accordance with IFRS, provides information that is helpful to understand the financial condition of the Company. The objective of using working capital is to present readers with a view of the Company from management's perspective by interpreting the material trends and activities that affect the short-term liquidity and financial position of the Company, including its ability to discharge its short-term liabilities as they come due. This measure is not comparable to similarly titled measures used by other public companies.

---

| | | |
|:---|:---|:---|
| *(in $ millions)* | **Mar 29, 2026** | Dec 28, 2025 |
| Cash and cash equivalents | **237.1** | 284.5 |
| Trade accounts receivable | **1009.7** | 955.7 |
| Inventories | **2417.7** | 2370.2 |
| Prepaid expenses, deposits and other current assets | **160.6** | 140.3 |
| Accounts payable and accrued liabilities | **(1051.2)** | (1264.2) |
| Income taxes payable | **(85.4)** | (80.8) |
| Current portion of lease obligations | **(59.4)** | (59.8) |
| Current portion of long-term debt | **(450.0)** | (450.0) |
| Dividends payable | **(45.8)** |  |
| Working capital | **2133.3** | 1895.9 |

---

Certain minor rounding variances exist between the unaudited condensed interim consolidated financial statements and this summary.

QUARTERLY REPORT - Q1 2026 P.42

## Exhibit 99.2

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS |

---

 **GILDAN ACTIVEWEAR INC.**

**CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION**

**(in thousands of U.S. dollars) - unaudited**

---

| | | |
|:---|:---|:---|
| | **March 29,<br>2026** | December 28,<br>2025 |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**237055** | $284458 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade accounts receivable (note 5) | **1009678** | 955670 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories (note 6) | **2417668** | 2370165 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses, deposits and other current assets | **160628** | 140271 |
| &nbsp;&nbsp;&nbsp;&nbsp;Assets held for sale (note 13) | **984957** | 959313 |
| Total current assets | **4809986** | 4709877 |
| Non-current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment | **1446236** | 1467719 |
| &nbsp;&nbsp;&nbsp;&nbsp;Right-of-use assets | **223262** | 234752 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible assets | **3006110** | 3021414 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | **839497** | 868848 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | **19370** | 22952 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-current assets | **128753** | 139675 |
| Total non-current assets | **5663228** | 5755360 |
| Total assets | $**10473214** | $10465237 |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | $**1051218** | $1264210 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | **85407** | 80764 |
| &nbsp;&nbsp;&nbsp;Current portion of lease obligations (note 9[(](#i6623d1712f2042aa901bfeab9623826b_46)d)) | **59432** | 59759 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends payable | **45844** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of long-term debt (note 7) | **450000** | 450000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Liabilities held for sale (note 13) | **358717** | 380923 |
| Total current liabilities | **2050618** | 2235656 |
| Non-current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt (note 7) | **4265100** | 3863680 |
| &nbsp;&nbsp;&nbsp;Lease obligations (note 9[(](#i6623d1712f2042aa901bfeab9623826b_46)d)) | **237243** | 254742 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | **374612** | 401097 |
| &nbsp;&nbsp;&nbsp;&nbsp;Employee benefit obligations | **108743** | 118409 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-current liabilities | **29112** | 29432 |
| Total non-current liabilities | **5014810** | 4667360 |
| Total liabilities | **7065428** | 6903016 |
| Equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Share capital | **2314045** | 2299475 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contributed surplus | **67975** | 112775 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | **1000358** | 1170259 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income (loss) (note 11) | **25408** | (20288) |
| Total equity attributable to shareholders of the Company | **3407786** | 3562221 |
| Total liabilities and equity | $**10473214** | $10465237 |

---

See accompanying notes to unaudited condensed interim consolidated financial statements.

 QUARTERLY REPORT - Q1 2026 43

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS |

---

**GILDAN ACTIVEWEAR INC.**

**CONDENSED INTERIM CONSOLIDATED STATEMENTS OF EARNINGS**

**AND COMPREHENSIVE INCOME**

**(in thousands of U.S. dollars, except per share data) - unaudited**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 29,<br>2026** | March 30,<br>2025 |
| Net sales (note 16) | $**1165944** | $711672 |
| Cost of sales (note 9(f)) | **887590** | 489735 |
| Gross profit | **278354** | 221937 |
| Selling, general and administrative expenses (notes 9(e), 9(f)) | **218654** | 87320 |
| Restructuring and acquisition-related costs (note 8) | **60977** | 4971 |
| Operating income (loss) | **(1277)** | 129646 |
| Financial expenses, net (note 9[(](#i6623d1712f2042aa901bfeab9623826b_46)b)) | **66734** | 29864 |
| Earnings (loss) before income taxes | **(68011)** | 99782 |
| Income tax expense (recovery) | **(12959)** | 15100 |
| Net earnings (loss) from continuing operations | **(55052)** | 84682 |
| Loss from discontinued operations, net of tax (note 13) | **(10737)** |  |
| Net earnings (loss) | $**(65789)** | $**84682** |
| Other comprehensive income (loss), net of related income taxes (note 11): |  |  |
| Cash flow hedges | $**29359** | $(10453) |
| Actuarial loss on employee benefit obligations | **(7)** |  |
| Translation adjustments | **16337** |  |
|  | $**45689** | $(10453) |
| Comprehensive income (loss) | $**(20100)** | $74229 |
| Earnings (loss) per share (note 12): |  |  |
| Basic earnings (loss) per share: |  |  |
| Continuing operations | $**(0.30)** | $0.56 |
| Discontinued operations | **(0.06)** |  |
| Total | $**(0.36)** | $0.56 |
| Diluted earnings (loss) per share: |  |  |
| Continuing operations | $**(0.30)** | $0.56 |
| Discontinued operations | **(0.06)** |  |
| Total | $**(0.36)** | $0.56 |

---

See accompanying notes to unaudited condensed interim consolidated financial statements.

 QUARTERLY REPORT - Q1 2026 44

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS |

---

**GILDAN ACTIVEWEAR INC.**

**CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY**

**Three months ended March 29, 2026 and March 30, 2025** 

**(in thousands or thousands of U.S. dollars) - unaudited**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Share capital | Share capital | Contributed<br>surplus | Accumulated<br>other<br>comprehensive<br>income (loss) | Retained<br>earnings | Total<br>equity |
| | Number | Amount | Contributed<br>surplus | Accumulated<br>other<br>comprehensive<br>income (loss) | Retained<br>earnings | Total<br>equity |
| Balance, December 28, 2025 | 185152 | $2299475 | $112775 | $(20288) | $1170259 | $3562221 |
| Share-based compensation |  |  | 12529 |  |  | 12529 |
| Shares issued under employee share purchase plan | 8 | 483 |  |  |  | 483 |
| Shares issued or distributed pursuant to vesting of restricted share units | 1105 | 27759 | (61072) |  |  | (33313) |
| Replacement awards (note 4) |  |  | 2641 |  |  | 2641 |
| Transaction costs on shares issued |  | (108) |  |  |  | (108) |
| Share repurchases for settlement of non-Treasury RSUs | (1092) | (13564) |  |  | (57901) | (71465) |
| Deferred compensation to be settled in non-Treasury RSUs |  |  | 1102 |  |  | 1102 |
| Dividends declared |  |  |  |  | (46204) | (46204) |
| Transactions with shareholders of the Company recognized directly in equity | 21 | 14570 | (44800) |  | (104105) | (134335) |
| Cash flow hedges (note 11) |  |  |  | 29359 |  | 29359 |
| Actuarial loss on employee benefit obligations |  |  |  |  | (7) | (7) |
| Translation adjustments (note 11) |  |  |  | 16337 |  | 16337 |
| Net earnings (loss) |  |  |  |  | (65789) | (65789) |
| Comprehensive income (loss) |  |  |  | 45696 | (65796) | (20100) |
| **Balance, March 29, 2026** | **185173** | $**2314045** | $**67975** | $**25408** | $**1000358** | $**3407786** |
| Balance, December 29, 2024 | 152411 | $268557 | $69920 | $(27) | $1118201 | $1456651 |
| Share-based compensation |  |  | 8820 |  |  | 8820 |
| Shares issued under employee share purchase plan | 8 | 404 |  |  |  | 404 |
| Shares issued pursuant to exercise of stock options | 283 | 11676 | (3246) |  |  | 8430 |
| Shares issued or distributed pursuant to vesting of restricted share units | 573 | 13158 | (34356) |  |  | (21198) |
| Shares repurchased for cancellation (including share buyback taxes) | (1240) | (2183) |  |  | (60352) | (62535) |
| Share repurchases for settlement of non-Treasury RSUs | (501) | (882) |  |  | (24875) | (25757) |
| Deferred compensation to be settled in non-Treasury RSUs |  |  | 1064 |  |  | 1064 |
| Dividends declared |  |  |  |  | (34625) | (34625) |
| Transactions with shareholders of the Company recognized directly in equity | (877) | 22173 | (27718) |  | (119852) | (125397) |
| Cash flow hedges (note 11) |  |  |  | (10453) |  | (10453) |
| Net earnings |  |  |  |  | 84682 | 84682 |
| Comprehensive income (loss) (note 11) |  |  |  | (10453) | 84682 | 74229 |
| Balance, March 30, 2025 | 151534 | $290730 | $42202 | $(10480) | $1083031 | $1405483 |

---

See accompanying notes to unaudited condensed interim consolidated financial statements.

 QUARTERLY REPORT - Q1 2026 45

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS |

---

**GILDAN ACTIVEWEAR INC.**

**CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(in thousands of U.S. dollars) - unaudited**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 29,<br>2026** | March 30,<br>2025 |
| Cash flows from (used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net earnings (loss) | $**(65789)** | $84682 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization (note 9(a)) | **54245** | 30345 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | **12577** | 8860 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | **(24491)** | (1082) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other (note 14(a)) | **(1513)** | 492 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in non-cash working capital balances (note 14(c)) | **(254503)** | (265530) |
| Cash flows from (used in) operating activities | **(279474)** | (142233) |
| Cash flows from (used in) investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase of property, plant and equipment | **(28700)** | (22278) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase of intangible assets | **(1589)** | (1041) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds on disposal of assets held for sale and other disposals of PP&E | **(123)** | 15 |
| Cash flows from (used in) investing activities | **(30412)** | (23304) |
| Cash flows from (used in) financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase in amounts drawn under long-term bank credit facility | **415000** | 75000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of Senior unsecured notes | **—** | 486280 |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayment of delayed draw term loan | **—** | (300000) |
| &nbsp;&nbsp;&nbsp;&nbsp;Share repurchases for settlement of non-Treasury RSUs | **(71465)** | (25757) |
| &nbsp;&nbsp;&nbsp;&nbsp;Repurchase and cancellation of shares | **—** | (61649) |
| &nbsp;&nbsp;&nbsp;&nbsp;Withholding taxes paid pursuant to the settlement of non-Treasury RSUs | **(52113)** | (21198) |
| &nbsp;&nbsp;&nbsp;&nbsp;Payment of lease obligations | **(22868)** | (4438) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other (note 14 (d)) | **(3306)** | (6116) |
| Cash flows from (used in) financing activities: | **265248** | 142122 |
| Effect of exchange rate changes on cash and cash equivalents denominated in foreign currencies | **1235** | 112 |
| Increase (decrease) in cash and cash equivalents during the period | **(43403)** | (23303) |
| Cash and cash equivalents, beginning of period | **294958** | 98799 |
| Cash and cash equivalents, end of period | $**251555** | $75496 |
| Balances in the condensed interim consolidated statements of financial position: |  |  |
| Cash and cash equivalents | $**237055** | $75496 |
| Cash and cash equivalents in current assets held for sale | **14500** |  |
| Cash and cash equivalents, end of period | $**251555** | $75496 |
| Cash paid during the period (included in cash flows from operating activities): | Cash paid during the period (included in cash flows from operating activities): | Cash paid during the period (included in cash flows from operating activities): |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest | $**46036** | $21883 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes, net of refunds | **11202** | 5046 |

---

Supplemental disclosure of cash flow information (note [1](#i6623d1712f2042aa901bfeab9623826b_76)4).

See accompanying notes to unaudited condensed interim consolidated financial statements.

The cash flows related to discontinued operations have not been segregated and remain included in the major classes of assets and liabilities. Accordingly, the Condensed Interim Consolidated Statements of Cash Flows include the results of continuing and discontinued operations.

 QUARTERLY REPORT - Q1 2026 46

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)**

**For the periods ended March 29, 2026** 

**(Tabular amounts in thousands or thousands of U.S. dollars except per share data, unless otherwise indicated)**

**1. REPORTING ENTITY:**

Gildan Activewear Inc. (the "Company" or "Gildan") is domiciled in Canada and is incorporated under the *Canada Business Corporations Act.* Its principal business activity is the manufacture and sale of activewear, hosiery, and underwear. The Company's fiscal year ends on the Sunday closest to December 31 of each year.

The address of the Company's registered office is 600 de Maisonneuve Boulevard West, Suite 3300, Montreal, Quebec. These unaudited condensed interim consolidated financial statements are as at and for the three months ended March 29, 2026 and include the accounts of the Company and its subsidiaries. The Company is a publicly listed entity and its shares are traded on the Toronto Stock Exchange and New York Stock Exchange under the symbol GIL.

**2. BASIS OF PREPARATION:**

**(a) Statement of compliance:**

These unaudited condensed interim consolidated financial statements have been prepared in accordance with International Accounting Standard ("IAS") 34, Interim Financial Reporting, as issued by the International Accounting Standards Board ("IASB"). These unaudited condensed interim consolidated financial statements should be read in conjunction with the Company's fiscal 2025 audited consolidated financial statements. The Company applied the same accounting policies in the preparation of these unaudited condensed interim consolidated financial statements as those disclosed in note 3 of its most recent annual consolidated financial statements, except for the adoption of new or amended accounting standards effective as of December 29, 2025 as described below in note 2(e).

These unaudited condensed interim consolidated financial statements were authorized for issuance by the Board of Directors of the Company on April 29, 2026.

**(b) Seasonality of the business:**

The Company's net sales are subject to seasonal variations. Net sales have historically been higher during the second and third quarters of the fiscal year.

**(c) Operating segments:**

The Company manages its business on the basis of one reportable operating segment.

**(d) Discontinued Operations:**

On December 1, 2025, when the Company purchased HanesBrands Inc ("Hanes"), the Company considered HanesBrands Australia ("HAA") to be as a component business acquired with a view to be resold. Immediately following the acquisition, management had taken steps to formalize its decision with the Board of Directors, engage financial advisors, identify potential buyers and commence a sale process. The Company expects to complete the sale of the business within twelve months from the date of acquisition.

As a result, the net assets of HAA acquired have been classified as held for sale and measured at their fair value less cost to sell as of the date of the Hanes acquisition. HAA has been classified as a discontinued operation in these condensed interim consolidated financial statements. Unless otherwise noted, discussion within these notes to the condensed interim consolidated financial statements relates to continuing operations. See Note 13 "Businesses Held for Sale and Discontinued Operations" for additional information about discontinued operations.

 QUARTERLY REPORT - Q1 2026 47

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**2. BASIS OF PREPARATION (continued):**

**(e) Initial application of new accounting standards and interpretations in the reporting period:**

<u>On December 29, 2025, the Company adopted the following new or amended accounting standards:</u> 

*IFRS 9 Financial Instruments ("IFRS 9") and IFRS 7 Financial Instruments: Disclosures ("IFRS 7")*<br>In May 2024, IASB issued limited amendments to IFRS 9 and IFRS 7. These amendments provide clarity on the timing of recognition and derecognition of financial assets and liabilities, the assessment of contractual cash flow characteristics, and the resulting classification and disclosure of financial assets with environmental, social, and governance-linked or other contingent features. Additionally, the amendments clarify that a financial liability is derecognized on the settlement date, with the accounting policy choice to derecognize a financial liability settled using an electronic payment system before the settlement date, provided specific conditions are met. Additional disclosures are required for financial instruments with contingent features and investments in equity instruments designated at fair value through other comprehensive income with these amendments. These amendments are effective for annual reporting periods beginning on or after January 1, 2026. The adoption of these standards, at the beginning of this interim period, was applied prospectively, in accordance with the respective transition provisions. The prospective application means that the new requirements are applied only to transactions, events, or balances occurring after the date of initial application, with no restatement of prior periods. The adoption of these standards did not have an impact on the Company's condensed interim consolidated financial statements for the period ended March 29, 2026. As a result, there were no adjustments to the opening balances of assets, liabilities, or equity as at the date of initial application.

**3. NEW ACCOUNTING STANDARDS AND INTERPRETATIONS NOT YET APPLIED:**

**IFRS 18 Presentation and Disclosure in Financial Statements**

On April 9, 2024, the IASB issued IFRS 18 to improve reporting of financial performance. IFRS 18 replaces IAS 1 Presentation of Financial Statements. It carries forward many requirements from IAS 1 unchanged. The standard sets out requirements on presentation and disclosures in financial statements. It introduces a defined structure for the statement of income composed of required categories and subtotals. The standard also introduces specific disclosure requirements for management-defined performance measures and a reconciliation between these measures and the most similar subtotal specified in IFRS, which must be disclosed in a single note. IFRS 18 applies for annual reporting periods beginning on or after January 1, 2027. Earlier application is permitted. The Company is currently evaluating the impact of the adoption of IFRS 18 on its consolidated financial statements.

**4. BUSINESS ACQUISITIONS:**

On December 1, 2025, the Company acquired 100% of the common shares of Hanes for a total purchase price of $2.3 billion. These consolidated financial statements include the results of Hanes as a consolidated subsidiary from December 1, 2025. Hanes is a global apparel company recognized for producing everyday clothing that emphasizes comfort, quality, and value. Its portfolio includes several iconic brands such as Hanes, the leading basic apparel brand in the U.S. The acquisition will allow the Company to expand scale and enhance its competitive position in the basic apparel market.

The Company accounted for this acquisition using the acquisition method in accordance with IFRS 3, Business Combinations. The Company determined the fair value of the assets acquired and liabilities assumed based on management's preliminary best estimate of their fair values and taking into account all relevant information available at that time. The Company has not yet finalized the assessment of the estimated fair value of assets acquired and liabilities assumed, which the Company expects to finalize by the one year anniversary of the acquisition date, at the latest. Goodwill is attributable primarily to the Hanes assembled workforce, business processes and the synergies expected to be achieved from integrating Hanes into the Company's existing business, which were not recorded separately since they did not meet the recognition criteria for identifiable intangible assets. Goodwill recorded in connection with this acquisition is not deductible for tax purposes.

 QUARTERLY REPORT - Q1 2026 48

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**4. BUSINESS ACQUISITIONS (continued):**

The following table summarizes the provisional amounts recognized for the assets acquired and liabilities assumed at the date of acquisition:

---

| | | | |
|:---|:---|:---|:---|
| | December 28, 2025 | Measurement-period adjustment<sup>1</sup> | March 29, 2026 |
| Assets acquired: |  |  |  |
| Trade accounts receivable | $316008 | $— | $316008 |
| Income taxes receivable | 18303 |  | 18303 |
| Inventories | 1131093 |  | 1131093 |
| Prepaid expenses, deposits and other current assets | 59421 |  | 59421 |
| Assets held for sale | 941203 | 16405 | 957608 |
| Property, plant and equipment | 310969 | 1696 | 312665 |
| Right-of-use assets | 138471 |  | 138471 |
| Other non-current assets | 59924 |  | 59924 |
| Deferred income taxes | 2517 |  | 2517 |
| Intangible assets | 2780494 | (2829) | 2777665 |
|  | $5758403 | $15272 | $5773675 |
| Liabilities assumed: |  |  |  |
| Accounts payable and accrued liabilities | $612644 | $— | $612644 |
| Income taxes payable | 60667 |  | 60667 |
| Current portion of lease obligations | 31422 | (1705) | 29717 |
| Current portion of long-term debt | 136047 |  | 136047 |
| Liabilities held for sale | 372520 | (10362) | 362158 |
| Lease obligations | 168191 | (3045) | 165146 |
| Long-term debt | 2334759 |  | 2334759 |
| Employee benefit obligations | 76461 |  | 76461 |
| Other non current liabilities | 16679 |  | 16679 |
| Deferred income taxes | 379154 | (1607) | 377547 |
|  | $4188544 | $(16719) | $4171825 |
| Goodwill | 597171 | (29351) | 567820 |
| Net assets acquired at fair value | $2167030 | $2640 | $2169670 |
| Cash consideration paid at closing, net of cash acquired | 122717 |  | 122717 |
| Issuance of common stock | 2014571 |  | 2014571 |
| Equity Awards | 29742 | 2640 | 32382 |
|  | $2167030 | $2640 | $2169670 |

---

1) The adjustments presented above relate to measurement period adjustments to the preliminary purchase price allocation (PPA) for the Hanes acquisition. These adjustments were made during the measurement period as permitted under IFRS 3, Business Combinations, and reflect new information obtained about facts and circumstances that existed as of the acquisition date, or corrections which are not material. The measurement period allows for the refinement of provisional amounts recognized at the acquisition date and does not exceed one year from the acquisition date. The measurement period adjustments were made in the current quarter, and the impact on the 2025 financial statements from retrospectively applying these adjustments to the consolidated statement of earnings is not material.

 QUARTERLY REPORT - Q1 2026 49

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**5. TRADE ACCOUNTS RECEIVABLE:**

---

| | | |
|:---|:---|:---|
| | **March 29,<br>2026** | December 28,<br>2025 |
| Trade accounts receivable | $**1019837** | $966762 |
| Allowance for expected credit losses | **(10159)** | (11092) |
|  | $**1009678** | $955670 |

---

As at March 29, 2026, trade accounts receivable being serviced under receivables purchase agreements amounted to $667.3 million (December 28, 2025 - $777.0 million). The three receivables purchase agreements allow for the sale of a maximum of $975 million, $400 million, and $150 million, respectively, of accounts receivables at any one time. The first agreement expires on June 16, 2026, subject to annual extensions, and the other two agreements do not have specified expiry dates and may be terminated by either party with 90 days' prior written notice. The Company retains servicing responsibilities, including collection, for these trade receivables sold. The difference between the carrying amount of the receivables sold under the agreements and the cash received at the time of transfer was $7.7 million (2025 - $3.5 million) for the three months ended March 29, 2026, and was recorded in bank and other financial charges.

The movement in the allowance for expected credit losses in respect of trade receivables was as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 29,<br>2026** | March 30,<br>2025 |
| Allowance for expected credit losses, beginning of period | $**(11092)** | $(11061) |
| Impairment of trade accounts receivable | **(288)** | (1977) |
| Write-off (Recovery) of trade accounts receivable | **1221** | 270 |
| Allowance for expected credit losses, end of period | $**(10159)** | $(12768) |

---

**6. INVENTORIES:**

---

| | | |
|:---|:---|:---|
| | **March 29,<br>2026** | December 28,<br>2025 |
| Raw materials and spare parts inventories | $**247400** | $253219 |
| Work in progress | **146880** | 145395 |
| Finished goods | **2023388** | 1971551 |
|  | $**2417668** | $2370165 |

---

 QUARTERLY REPORT - Q1 2026 50

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**7. LONG-TERM DEBT:**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Effective interest rate**<sup>(1)</sup> | **Principal amount** | **Principal amount** | **Maturity date** |
| | **Effective interest rate**<sup>(1)</sup> | **March 29,<br>2026** | December 28,<br>2025 | **Maturity date** |
| **Non-current portion of long-term debt** |  |  |  |  |
| Revolving long-term bank credit facility, interest at variable U.S. interest rate<sup>(2)(3)</sup> | **5.2%** | $**655000** | $240000 | **Mar 2031** |
| Senior unsecured Canadian notes, Series 1, interest at fixed rate of 4.36%, payable semi-annually | **5.5%** | **360750** | 365600 | **Nov 2029** |
| Senior unsecured Canadian notes, Series 2, interest at fixed rate of 4.71%, payable semi-annually | **5.8%** | **144300** | 146240 | **Nov 2031** |
| Senior unsecured Canadian notes, Series 3, interest at CORRA plus 1.26%, payable quarterly | **5.1%** | **108225** | 109680 | **Mar 2028** |
| Senior unsecured Canadian notes, Series 4, interest at fixed rate of 3.630%, payable semi-annually | **5.4%** | **144300** | 146240 | **Mar 2028** |
| Senior unsecured Canadian notes, Series 5, interest at fixed rate of 4.149%, payable semi-annually | **5.6%** | **252525** | 255920 | **Nov 2030** |
| Senior unsecured U.S., Series 1, interest at fixed rate of 4.70%, payable semi-annually  | **4.7%** | **600000** | 600000 | **Oct 2030** |
| Senior unsecured U.S., Series 2, interest at fixed rate of 5.40%, payable semi-annually | **5.4%** | **600000** | 600000 | **Oct 2035** |
| Term loan, interest at variable U.S. interest rate, payable monthly<sup>(5)</sup> | **5.2%** | **300000** | 300000 | **Aug 2029** |
| Term loan, interest at variable U.S. interest rate, payable monthly<sup>(5)</sup> | **5.4%** | **600000** | 600000 | **Dec 2028** |
| Term loan, interest at variable U.S. interest rate, payable monthly<sup>(5)</sup> | **5.2%** | **500000** | 500000 | **Dec 2027** |
|  |  | $**4265100** | $3863680 |  |
| **Current portion of long-term debt** |  |  |  |  |
| Notes payable, interest at fixed rate of 2.91%, payable semi-annually<sup>(6)</sup> | **2.9%** | $**100000** | $100000 | **Aug 2026** |
| Notes payable, interest at Adjusted SOFR plus a spread of 1.57%, payable quarterly<sup>(6)(7)</sup> | **2.9%** | **50000** | 50000 | **Aug 2026** |
| Term loan, interest at variable U.S. interest rate, payable monthly<sup>(2)(4)</sup> | **4.8%** | **300000** | 300000 | **Jun 2026** |
|  |  | $**450000** | $450000 |  |
| **Long-term debt (including current portion)** |  | $**4715100** | $4313680 |  |

---

(1)Represents the annualized effective interest rate for the three months ended March 29, 2026, including the impact of interest rate swaps and cross currency interest rate swaps, where applicable.

(2)Secured Overnight Financing Rate (SOFR) advances plus a spread ranging from 1% to 3%.

(3)The Company's committed unsecured revolving long-term bank credit facility of $1.6 billion provides for an annual extension which is subject to the approval of the lenders. The spread added to the adjusted Term SOFR is a function of the Company's credit rating (as defined in the credit facility agreement and its amendments). In addition, an amount of $31.7 million (December 28, 2025 - $30.7 million) has been committed against this facility to cover various letters of credit.

(4)The unsecured term loan is non-revolving and can be prepaid in whole or in part at any time with no penalties. The spread added to the adjusted Term SOFR is a function of the total net debt to EBITDA ratio (as defined in the term loan agreements and its amendments). The term loan matures on June 30, 2026.

(5)The term loan facility can be prepaid in whole or in part at any time with no penalties. U.S. Base Rate Advances at U.S. Base rates or SOFR advances plus a spread ranging from 1% to 2% based on the Company's credit rating (as defined in the term loan agreements and its amendments).

(6)The unsecured notes issued to accredited investors in the U.S. private placement market can be prepaid in whole or in part at any time, subject to the payment of a prepayment penalty as provided for in the Note Purchase Agreement.

(7)Adjusted SOFR rate is determined on the basis of floating rate notes that bear interest at a floating rate plus a spread of 1.57%.

 QUARTERLY REPORT - Q1 2026 51

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**7. LONG-TERM DEBT (continued):**

On March 20, 2026 the Company amended its unsecured revolving long-term bank credit facility to increase the aggregate revolving commitments from $1.2 billion to $1.6 billion, effective the same date.

Under the terms of the revolving facility, term loan facilities and U.S. private notes, the Company is required to comply with certain covenants, including maintenance of financial ratios. The Company was in compliance with all financial covenants as at March 29, 2026.

**8. RESTRUCTURING AND ACQUISITION-RELATED COSTS (RECOVERIES):**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 29,<br>2026** | March 30,<br>2025 |
| Employee termination and benefit costs | $**27109** | $— |
| Exit, relocation and other costs | **1667** | 2695 |
| Net loss (gain) on disposal, and write-downs of property, plant and equipment, right-of-use assets and computer software related to exit activities | **14407** | 2276 |
| Acquisition-related transaction and integration costs | **17794** |  |
| Restructuring and acquisition-related costs | $**60977** | $4971 |

---

Restructuring and acquisition-related costs for the three months ended March 29, 2026 primarily reflect expenses associated with the integration of Hanes. These costs include $27.1 million for severance and other related charges (including severance costs arising from the closure of a hosiery manufacturing facility in Honduras and a textile manufacturing facility in Bangladesh), and $14.5 million for the write-off of equipment related to these facility closures.

In addition, $12.9 million was incurred for other integration-related expenses, such as consulting and IT costs. The period also includes $2.2 million in transaction costs related to the sale of HAA, which is classified as a discontinued operation, $2.0 million in additional transaction costs, and $1.4 million in other exit and relocation costs associated with the closure of the hosiery manufacturing facility. The remaining $0.8 million relates to restructuring activities initiated in previous years. Restructuring and acquisition-related costs for the three months ended March 30, 2025, included $2.5 million for the closure of a U.S. yarn-spinning facility, and other charges including costs relating to

restructuring activities initiated in previous years.

Subsequent to the end of the first quarter, the Company undertook additional restructuring and integration initiatives. The costs associated with these new actions, including any related severance, facility closure, and integration expenses, will be recognized in the second quarter of fiscal 2026 in accordance with the Company's accounting policies and applicable accounting standards.

 QUARTERLY REPORT - Q1 2026 52

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**9. OTHER INFORMATION:**

**(a) Depreciation and amortization:**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 29,<br>2026** | March 30,<br>2025 |
| Depreciation of property, plant and equipment | $**33446** | $28918 |
| Depreciation of right-of-use assets | **11950** | 3941 |
| Adjustment for the variation of depreciation included in inventories at the beginning and end of the period | **(5508)** | (5666) |
| Amortization of intangible assets, excluding computer software | **11661** | 1923 |
| Amortization of computer software | **2696** | 1229 |
| Depreciation and amortization included in net earnings | $**54245** | $30345 |

---

Included in property, plant and equipment as at March 29, 2026 is $38.9 million (December 28, 2025 - $47.1 million) of buildings and equipment not yet available for use in operations. Included in intangible assets as at March 29, 2026 is $6.1 million (December 28, 2025 - $5.6 million) of software not yet available for use in operations. Depreciation and amortization on these assets commence when the assets are available for use.

As at March 29, 2026, the Company has approximately $57.9 million in commitments to purchase property and equipment, mainly related to manufacturing operations.

**(b) Financial expenses, net:**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 29,<br>2026** | March 30,<br>2025 |
| Interest expense on financial liabilities recorded at amortized cost | $**52419** | $24034 |
| Bank and other financial charges | **9849** | 5547 |
| Interest accretion on discounted lease obligations | **3717** | 1490 |
| Interest accretion on discounted provisions | **126** |  |
| Foreign exchange loss (gain) | **623** | (1207) |
| Financial expenses, net | $**66734** | $29864 |

---

**(c) Related party transaction:**

The Company incurred expenses for aircraft and other services of $0.3 million (2025 - $0.3 million), for the three months ended March 29, 2026, with a company controlled by the President and Chief Executive Officer of the Company. The payments made are in accordance with the terms of the agreement established and agreed to by the related parties. As at March 29, 2026, the amount in accounts payable and accrued liabilities related to the airplane usage was $0.2 million (December 28, 2025 - $0.1 million).

As at March 29, 2026, the Company has a commitment of $0.6 million under this agreement, which relates to minimum usage fees for the remainder of fiscal 2026.

 QUARTERLY REPORT - Q1 2026 53

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**9. OTHER INFORMATION (continued):**

**(d) Lease obligations:** 

The Company's leases are primarily for manufacturing, sales, distribution, and administrative facilities.

The following table presents lease obligations recorded in the condensed interim consolidated statements of financial position:

---

| | | |
|:---|:---|:---|
| | **March 29,<br>2026** | December 28,<br>2025 |
| Current | $**59432** | $59759 |
| Non-current | **237243** | 254742 |
|  | $**296675** | $314501 |

---

The following table presents the future minimum lease payments under non-cancellable leases (including short-term leases) as at March 29, 2026:

---

| | |
|:---|:---|
| | **March 29,<br>2026** |
| Less than one year | $**65204** |
| One to five years | **193596** |
| More than five years | **86611** |
|  | $**345411** |

---

For the three months ended March 29, 2026, the total cash outflow for recognized lease obligations (including interest) was $17.1 million (2025 - $5.9 million), of which $13.4 million (2025 - $4.4 million), was included as part of cash outflows used in financing activities.

**(e) Costs relating to proxy contest and leadership changes and related matters:**

For the three months ended March 29, 2026, costs relating to proxy contest and leadership changes and related matters included in SG&A expenses amounted to $0.8 million (2025 - $0.9 million), respectively, and included the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Advisory fees on shareholder matters of $0.8 million (2025 - $0.6 million);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Stock-based compensation relating to special retention awards, net of jobs credits, of nil (2025 - $0.2 million); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Incremental costs relating to the previous Board and refreshed Board of nil (2025 - $0.1 million). This charge relates to the increase in value of the deferred share units (DSU) liability.

**(f) Government assistance:**

For the three months ended March 29, 2026 the Company recognized $5.1 million (2025 - $4.5 million) in cost of sales relating to government assistance for production costs.

During the second quarter of fiscal 2024, the Government of Barbados enacted a jobs credit, in order to foster economic activity and employment in Barbados. For the three months ended March 29, 2026 the Company recognized $11.4 million (2025 - $8.1 million), for this jobs credit, as a reduction of SG&A expenses in the condensed interim consolidated statements of earnings and comprehensive income.

 QUARTERLY REPORT - Q1 2026 54

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**10. FAIR VALUE MEASUREMENT:**

**Financial instruments – carrying amounts and fair values:**

The carrying amounts and fair values of financial assets and liabilities included in the unaudited condensed interim consolidated statements of financial position are as follows:

---

| | | |
|:---|:---|:---|
| | **March 29,<br>2026** | December 28,<br>2025 |
| **Financial assets** |  |  |
| Amortized cost: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**237055** | $284458 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade accounts receivable | **1009678** | 955670 |
| &nbsp;&nbsp;&nbsp;Financial assets included in prepaid expenses, deposits and other current assets | **72607** | 69234 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term non-trade receivables included in other non-current assets | **59638** | 65519 |
| Fair value through other comprehensive income: |  |  |
| &nbsp;&nbsp;&nbsp;Derivative financial assets included in prepaid expenses, deposits and other current assets | **29969** | 3493 |
| &nbsp;&nbsp;&nbsp;Derivative financial assets included in other non-current assets | **8214** | 23242 |
| **Financial liabilities** |  |  |
| Amortized cost: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities<sup>(1)</sup> | $**1048047** | $1251927 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt - bearing interest at variable rates | **2513225** | 2099680 |
| &nbsp;&nbsp;&nbsp;Long-term debt - bearing interest at fixed rates<sup>(2)</sup> | **2201875** | 2214000 |
| Fair value through other comprehensive income: |  |  |
| &nbsp;&nbsp;&nbsp;Derivative financial liabilities included in accounts payable and accrued liabilities | **3171** | 12283 |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivative financial liabilities included in other non-current liabilities | **3292** |  |

---

(1) Accounts payable and accrued liabilities include $76.4 million (December 28, 2025 - $78.1 million) under supply-chain financing arrangements (reverse factoring) with a financial institution, whereby receivables due from the Company to certain suppliers can be collected by the suppliers from a financial institution before their original due date. These balances are classified as accounts payable and accrued liabilities and the related payments as cash flows from operating activities, given the principal business purpose of the arrangement is to provide funding to the supplier and not the Company, the arrangement does not significantly extend the payment terms beyond the normal terms agreed with other suppliers, and no additional deferral or special guarantees to secure the payments are included in the arrangement. Accounts payable and accrued liabilities also include balances payable of $39.9 million (December 28, 2025 - $120.1) resulting mainly from a one-week timing difference between the collection of sold receivables and the weekly remittance to the bank counterparty under the receivables purchase agreement that is disclosed in note 5 to these unaudited condensed interim consolidated financial statements.

(2) The fair value of the long-term debt bearing interest at fixed rates was $2,213.7 million as at March 29, 2026 (December 28, 2025 - $2,229.6 million).

 QUARTERLY REPORT - Q1 2026 55

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**10. FAIR VALUE MEASUREMENT (continued):**

***Short-term financial assets and liabilities***

The Company has determined that the fair value of its short-term financial assets and liabilities approximates their respective carrying amounts as at the reporting dates due to the short-term maturities of these instruments, as they bear variable interest-rates or because the terms and conditions are comparable to current market terms and conditions for similar items.

***Non-current assets and long-term debt bearing interest at variable rates***

The fair values of the long-term non-trade receivables included in other non-current assets and the Company's long-term debt bearing interest at variable rates also approximate their respective carrying amounts because the interest rates applied to measure their carrying amounts approximate current market interest rates.

***Long-term debt bearing interest at fixed rates***

The fair value of the long-term debt bearing interest at fixed rates is determined using the discounted future cash flows method and at discount rates based on yield to maturities for similar issuances. The fair value of the long-term debt bearing interest at fixed rates was measured using Level 2 inputs in the fair value hierarchy. In determining the fair value of the long-term debt bearing interest at fixed rates, the Company takes into account its own credit risk and the credit risk of the counterparties.

***Derivatives***

Derivative financial instruments are designated as effective hedging instruments and consist of foreign exchange and commodity forward, option, and swap contracts, as well as floating-to-fixed interest rate swaps to fix the variable interest rates on a designated portion of borrowings under the term loan and unsecured notes. The fair value of the forward contracts is measured using a generally accepted valuation technique which is the discounted value of the difference between the contract's value at maturity based on the rate set out in the contract and the contract's value at maturity based on the rate that the counterparty would use if it were to renegotiate the same contract terms at the measurement date under current conditions. The fair value of the option contracts is measured using option pricing models that utilize a variety of inputs that are a combination of quoted prices and market-corroborated inputs, including volatility estimates and option adjusted credit spreads. The fair value of the interest rate swaps is determined based on market data, by measuring the difference between the fixed contracted rate and the forward curve for the applicable floating interest rates.

The Company has also entered into derivative transactions to hedge its exposure to foreign currency exchange risk related to its series 1,2,3 and 5 notes liability and interest expense denominated in Canadian dollars. These cross-currency swaps were designated at inception and are accounted for as a cash flow hedges, and to the extent that the hedges are effective, the portion of the change in fair value of the swaps that is attributable to the hedged foreign-currency risk is recognized in other comprehensive income. Amounts accumulated in OCI are reclassified to the statement of income as the hedged interest payments impact net income and as the revaluation of the principal on the notes affects profit or loss.

The Company also entered into derivative transactions to hedge its exposure to foreign currency exchange risk related to its Series 4 notes liability and fixed interest expense denominated in Canadian dollars. The cross-currency swap has been designated at inception and is accounted for as a fair value hedge of the changes in fair value arising from the changes in the risk-free interest rate and foreign currency exchange rate. The carrying amount of the Series 4 notes liability is adjusted for the fair value change attributable to the hedged risk with a corresponding entry in profit or loss. The fair value changes on the cross-currency swap are recognized in profit or loss within the same line item.

Derivative financial instruments were measured using Level 2 inputs in the fair value hierarchy. In determining the fair value of derivative financial instruments the Company takes into account its own credit risk and the credit risk of the counterparties.

 QUARTERLY REPORT - Q1 2026 56

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**11. OTHER COMPREHENSIVE INCOME (LOSS) ("OCI"):**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 29,<br>2026** | March 30,<br>2025 |
| Net gain (loss) on derivatives designated as cash flow hedges: | Net gain (loss) on derivatives designated as cash flow hedges: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency risk | $**(19628)** | $(755) |
| &nbsp;&nbsp;&nbsp;&nbsp;Commodity price risk | **41177** | (4149) |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate risk | **(1042)** | (78) |
| Income taxes | **(2544)** | 7 |
| Amounts reclassified from OCI to inventory, related to commodity price risk | **(7199)** | 2027 |
| Amounts reclassified from OCI to net earnings, related to foreign currency risk, commodity price risk, and interest rate risk, and included in: | Amounts reclassified from OCI to net earnings, related to foreign currency risk, commodity price risk, and interest rate risk, and included in: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | **501** | (1557) |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | **(270)** | 665 |
| &nbsp;&nbsp;&nbsp;&nbsp;Financial expenses, net | **18461** | (6689) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes | **(97)** | 76 |
| Translation adjustments | **16337** |  |
| Other comprehensive income (loss) | $**45696** | $(10453) |

---

As at March 29, 2026, accumulated other comprehensive gains of $25.4 million consisted of net deferred gains from translation adjustments of $33.2 million, net deferred gains on commodity forward, option, and swap contracts of $8.3 million, net deferred gain on interest rate swaps of $0.8 million, net deferred gain on forward foreign exchange contracts of $0.2 million, partially offset by net deferred losses on cross currency interest rate swap contracts of $15.8 million and net deferred tax payable of $1.3 million. Approximately $2.9 million of net losses presented in accumulated other comprehensive income are expected to be reclassified to inventory or net earnings within the next twelve months.

 QUARTERLY REPORT - Q1 2026 57

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**12. EARNINGS (LOSS) PER SHARE:**

Reconciliation between basic and diluted earnings per share is as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 29,<br>2026** | March 30,<br>2025 |
| Net earnings (loss) |  |  |
| Continuing operations | $**(55052)** | $84682 |
| Discontinued operations | **(10737)** | **—** |
| Total | $**(65789)** | $84682 |
| Basic earnings (loss) per share: |  |  |
| Continuing operations | $**(0.30)** | $0.56 |
| Discontinued operations | **(0.06)** |  |
| Total | $**(0.36)** | $0.56 |
| Diluted earnings (loss) per share: |  |  |
| Continuing operations | $**(0.30)** | $0.56 |
| Discontinued operations | **(0.06)** |  |
| Total | $**(0.36)** | $0.56 |
| Basic weighted average number of common shares outstanding | **185158** | 151875 |
| Plus dilutive impact of stock options, Treasury RSUs, and common shares held in trust | **—** | 115 |
| Diluted weighted average number of common shares outstanding | **185158** | 151990 |

---

Excluded from the above calculation for the three months ended March 29, 2026 are 1.6 million treasury RSUs (2025 - 1.5 million), which are considered contingently issuable shares for which performance conditions have not been met as at March 29, 2026.

Excluded from the above calculation for the three months ended March 29, 2026 are 35,956 Treasury RSUs which were deemed to be anti-dilutive.

 QUARTERLY REPORT - Q1 2026 58

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**13. BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS:** 

In December 2024, Hanes finalized plans to exit the Champion Japan business. The final sale is expected to be completed in fiscal 2026, and therefore the assets and liabilities of Champion Japan are recorded as held for sale. As described in note 2d, the assets and liabilities of HAA are reported as held for sale, and HAA's results of operations are classified as discontinued operations.

Assets and liabilities of businesses classified as held for sale in the condensed interim consolidated statements of financial position consist of the following:

---

| | | |
|:---|:---|:---|
| | **March 29,<br>2026** | December 28,<br>2025 |
| Assets held for sale - HAA | $**919856** | $**906236** |
| Assets held for sale - Champion Japan | **65101** | **53077** |
|  | $**984957** | $**959313** |
| Liabilities held for sale - HAA | $**302715** | $**309262** |
| Liabilities held for sale - Champion Japan | **56002** | **71661** |
|  | $**358717** | $**380923** |

---

The key components of the operating results of the discontinued operations are as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 29,<br>2026** | March 30,<br>2025 |
| Net sales | $**189158** | $— |
| Cost of sales | **109454** |  |
| Gross profit | **79704** |  |
| Selling, general and administrative expenses | **75499** |  |
| Operating income | **4205** |  |
| Other expenses | **109** |  |
| Financial expenses, net | **11257** |  |
| Loss from discontinued operations, before income taxes | **(7161)** |  |
| Income tax expense | **3576** |  |
| Loss from discontinued operations, net of tax | $**(10737)** | $— |

---

 QUARTERLY REPORT - Q1 2026 59

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**14. SUPPLEMENTAL CASH FLOW DISCLOSURE:**

**(a) Adjustments to reconcile net earnings to cash flows from (used in) operating activities - other items:**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 29,<br>2026** | March 30,<br>2025 |
| Unrealized net loss on foreign exchange and financial derivatives | $**7541** | $1770 |
| Non-cash restructuring (recoveries) costs related to property, plant and equipment (PP&E), right-of-use assets, and computer software (note 8) | **14407** | 2276 |
| Timing differences between settlement of financial derivatives and transfer of deferred gains or losses in accumulated OCI to inventory and net earnings | **(5753)** | 683 |
| Gain (loss) on disposal of PP&E, intangible assets, and right-of-use assets | **139** | (91) |
| Other non-current assets | **(5125)** | (2549) |
| Other non-current liabilities | **(12722)** | (1597) |
|  | $**(1513)** | $492 |

---

**(b) Variations in non-cash transactions:**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 29,<br>2026** | March 30,<br>2025 |
| Net additions to property, plant and equipment and intangible assets included in accounts payable and accrued liabilities | $**(1813)** | $264 |
| Proceeds on disposal of property, plant and equipment and computer software included in other current assets | **(455)** |  |
| Amounts payable relating to taxes on share repurchases included in accounts payable and accrued liabilities | **—** | 926 |
| Additions to right-of-use assets included in lease obligations | **(2)** | 291 |
| Shares repurchased for cancellation included in accounts payable and accrued liabilities | **—** | (40) |
| Non-cash ascribed value credited to share capital from shares issued or distributed pursuant to vesting of restricted share units and exercise of stock options | **27759** | 16404 |
| Deferred compensation credited to contributed surplus | **(1102)** | (1064) |
| Withholding taxes payable pursuant to the settlement of non-Treasury RSUs | **(18800)** |  |
| Dividends payable | **46204** | 34625 |

---

 QUARTERLY REPORT - Q1 2026 60

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**14. SUPPLEMENTAL CASH FLOW DISCLOSURE (continued):**

**(c) Changes in working capital balances:**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 29,<br>2026** | March 30,<br>2025 |
| Trade accounts receivable | $**(44651)** | $(118561) |
| Income taxes | **9617** | 3020 |
| Inventories | **(12408)** | (116642) |
| Prepaid expenses, deposits and other current assets | **4465** | (1127) |
| Accounts payable and accrued liabilities | **(211526)** | (32220) |
|  | $**(254503)** | $(265530) |

---

**(d) Cash flows used in financing activities - other items:**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 29,<br>2026** | March 30,<br>2025 |
| Proceeds from the issuance of shares | $**435** | $8794 |
| Payment of tax on shares repurchased for cancellation under normal course issuer bid program | **(3330)** | (14910) |
| Transaction costs on equity issuance | **(108)** |  |
| Deferred financing costs | **(303)** |  |
|  | $**(3306)** | $(6116) |

---

**15. CONTINGENT LIABILITIES:**

**Claims and litigation**

The Company is a party to claims and litigation arising in the normal course of operations. The Company does not expect the resolution of these matters to have a material adverse effect on the financial position or results of operations of the Company.

The Company records a liability when it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. Significant judgment is required to determine both the probability of having incurred a liability and the estimated amount of the liability. The Company reviews these matters at least quarterly and adjusts these liabilities to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other updated information and events, pertaining to a particular case.

 QUARTERLY REPORT - Q1 2026 61

------

---

| | |
|:---|:---|
| ![image3a.jpg](image3a.jpg) | NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) |

---

**16. DISAGGREGATION OF REVENUE:**

As a result of the Hanes acquisition, the Company has implemented a realignment of its internal sales teams to more closely align with its go-to-market strategy. As a result, effective the first quarter of fiscal 2026, the Company has transitioned from disclosing net sales for Activewear and Innerwear to providing the same information on a Retail and Wholesale basis. Wholesale comprises sales to distributors, screenprinters, embellishers and global lifestyle brand customers. Retail comprises sales to mass merchants, department stores, national chains, specialty retailers, online retailers and directly to consumers.

Net sales by channel were as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 29,<br>2026** | March 30,<br>2025 |
| Wholesale | $**552060** | $626400 |
| Retail | **613884** | 85272 |
|  | $**1165944** | $711672 |

---

The Company recasted comparative figures to conform to the current period's presentation.

Net sales were derived from customers located in the following geographic areas:

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **March 29,<br>2026** | March 30,<br>2025 |
| United States | $**1069078** | $632561 |
| Canada | **24953** | 27934 |
| International | **71913** | 51177 |
|  | $**1165944** | $711672 |

---

 QUARTERLY REPORT - Q1 2026 62

## Exhibit 99.3

**FORM 52-109F2**

**CERTIFICATION OF INTERIM FILINGS**

**FULL CERTIFICATE**

I, Glenn J. Chamandy, President and Chief Executive Officer of Gildan Activewear Inc., certify the following:

1. ***Review:*** I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of **Gildan Activewear Inc.** (the "issuer") for the interim period ended **March 29, 2026**.

2. ***No misrepresentations:*** Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

3. ***Fair presentation:*** Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, results of operations and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

4. ***Responsibility:*** The issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 *Certification of Disclosure in Issuers' Annual and Interim Filings*, for the issuer.

5. ***Design:*** Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer's other certifying officer(s) and I have, as at the end of the period covered by the interim filings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A.&nbsp;&nbsp;&nbsp;&nbsp;designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I.&nbsp;&nbsp;&nbsp;&nbsp;material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;II.&nbsp;&nbsp;&nbsp;&nbsp;information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B.&nbsp;&nbsp;&nbsp;&nbsp;designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer's GAAP.

5.1 ***Control framework:*** The control framework the issuer's other certifying officer(s) and I used to design the issuer's ICFR is the framework set forth in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

5.2 ***ICFR - material weakness relating to design:*** N/A

5.3 ***Limitation on scope of design:*** The issuer has disclosed in its interim MD&A

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A.the fact that the issuer's other certifying officer(s) and I have limited the scope of our design of DC&P and ICFR to exclude controls, policies and procedures of a business that the issuer acquired not more than 365 days before the last day of the period covered by the interim filings; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B.summary financial information about the business that the issuer acquired that has been consolidated in the issuer's financial statements.

6. ***Reporting changes in ICFR:*** The issuer has disclosed in its interim MD&A any change in the issuer's ICFR that occurred during the period beginning on **December 29, 2025** and ended on **March 29, 2026** that has materially affected, or is reasonably likely to materially affect, the issuer's ICFR.

Date: **April 30, 2026**

*<u>(s) Glenn J. Chamandy</u>&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Glenn J. Chamandy

President and Chief Executive Officer

## Exhibit 99.4

**FORM 52-109F2**

**CERTIFICATION OF INTERIM FILINGS**

**FULL CERTIFICATE**

I, Luca Barile, Executive Vice-President, Chief Financial Officer of Gildan Activewear Inc., certify the following:

1. ***Review:*** I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of **Gildan Activewear Inc.** (the "issuer") for the interim period ended **March 29, 2026**.

2. ***No misrepresentations:*** Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

3. ***Fair presentation:*** Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, results of operations and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.

4. ***Responsibility:*** The issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 *Certification of Disclosure in Issuers' Annual and Interim Filings*, for the issuer.

5. ***Design:*** Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer's other certifying officer(s) and I have, as at the end of the period covered by the interim filings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A.&nbsp;&nbsp;&nbsp;&nbsp;designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I.&nbsp;&nbsp;&nbsp;&nbsp;material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;II.&nbsp;&nbsp;&nbsp;&nbsp;information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B.&nbsp;&nbsp;&nbsp;&nbsp;designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer's GAAP.

5.1 ***Control framework:*** The control framework the issuer's other certifying officer(s) and I used to design the issuer's ICFR is the framework set forth in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

5.2 ***ICFR - material weakness relating to design:*** N/A

5.3 ***Limitation on scope of design:*** The issuer has disclosed in its interim MD&A

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A.the fact that the issuer's other certifying officer(s) and I have limited the scope of our design of DC&P and ICFR to exclude controls, policies and procedures of a business that the issuer acquired not more than 365 days before the last day of the period covered by the interim filings; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B.summary financial information about the business that the issuer acquired that has been consolidated in the issuer's financial statements.

6. ***Reporting changes in ICFR:*** The issuer has disclosed in its interim MD&A any change in the issuer's ICFR that occurred during the period beginning on **December 29, 2025** and ended on **March 29, 2026** that has materially affected, or is reasonably likely to materially affect, the issuer's ICFR.

Date: **April 30, 2026**

*<u>(s) Luca Barile</u>*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Luca Barile

Executive Vice-President, Chief Financial Officer

<br>